data_2l6c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l6c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.449 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.449 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.465 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.47 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.553 0.692 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.426 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.447 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -160.37 148.51 16.56 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.35 1.46 . . . . 0.0 111.335 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.88 24.02 1.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.321 1.448 . . . . 0.0 111.923 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 52.17 -103.19 0.15 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.833 1.653 . . . . 0.0 112.599 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.13 -0.8 22.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.074 1.35 . . . . 0.0 113.05 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.449 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.449 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.019 0.437 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.8 p -83.48 178.88 7.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.428 1.091 . . . . 0.0 112.999 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.96 14.1 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.602 1.161 . . . . 0.0 113.834 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.465 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -115.21 -162.23 0.82 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.791 1.636 . . . . 0.0 111.736 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.42 12.1 4.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.162 1.385 . . . . 0.0 113.705 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.47 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -74.29 -179.73 4.08 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.938 -1.101 . . . . 0.0 112.836 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.7 11.93 8.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.466 1.506 . . . . 0.0 113.795 -163.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -119.89 175.43 5.9 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 112.361 175.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.28 1.3 27.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.01 -166.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -156.86 150.34 24.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.227 1.811 . . . . 0.0 110.602 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.59 18.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.016 1.326 . . . . 0.0 113.623 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -170.33 160.13 7.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.457 1.103 . . . . 0.0 112.082 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.84 25.53 1.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.926 1.29 . . . . 0.0 112.291 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -160.99 178.55 9.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.28 1.032 . . . . 0.0 112.217 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.31 10.52 27.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.414 1.485 . . . . 0.0 113.43 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -82.69 142.96 31.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.393 1.077 . . . . 0.0 111.676 172.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.46 16.8 12.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 112.031 166.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 p -77.22 148.71 35.68 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.478 1.111 . . . . 0.0 113.097 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.31 22.73 1.34 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.856 1.262 . . . . 0.0 112.655 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -83.55 -176.28 6.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.829 1.252 . . . . 0.0 113.308 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.26 8.99 38.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.56 1.544 . . . . 0.0 112.829 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -84.67 -175.35 5.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.42 18.62 15.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.245 1.818 . . . . 0.0 112.409 -168.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -68.16 173.14 4.94 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.969 -1.082 . . . . 0.0 113.245 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 11.89 3.85 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.213 1.405 . . . . 0.0 113.713 -162.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.428 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.878 0.847 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p -86.19 158.95 19.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.233 1.413 . . . . 0.0 112.789 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.18 27.83 0.84 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.798 1.239 . . . . 0.0 113.096 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -162.63 154.49 18.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.018 1.727 . . . . 0.0 110.816 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.48 7.41 6.98 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -72.27 62.63 0.5 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.245 1.818 . . . . 0.0 112.412 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.77 3.88 21.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.774 1.629 . . . . 0.0 113.386 -164.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.13 0.491 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -154.09 170.82 20.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.386 1.075 . . . . 0.0 111.623 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.62 15.05 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.027 1.331 . . . . 0.0 113.155 -161.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -158.84 166.24 32.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.925 1.69 . . . . 0.0 111.448 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 13.53 4.19 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.441 1.096 . . . . 0.0 113.455 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.447 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.447 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -64.81 164.15 12.86 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.999 1.72 . . . . 0.0 113.807 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.4 26.06 1.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 113.417 -167.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.436 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.461 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.406 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 37' ' ' MET . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.419 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.553 0.692 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HD3' ' A' ' 94' ' ' PRO . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD3' HG12 ' A' ' 40' ' ' VAL . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.439 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.423 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 24' ' ' VAL . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 41' ' ' LEU . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.473 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -160.37 148.51 16.56 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.35 1.46 . . . . 0.0 111.335 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.88 24.02 1.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.321 1.448 . . . . 0.0 111.923 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 52.17 -103.19 0.15 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.833 1.653 . . . . 0.0 112.599 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.13 -0.8 22.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.074 1.35 . . . . 0.0 113.05 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.436 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.019 0.437 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.8 p -83.48 178.88 7.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.428 1.091 . . . . 0.0 112.999 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.96 14.1 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.602 1.161 . . . . 0.0 113.834 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.461 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -115.21 -162.23 0.82 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.791 1.636 . . . . 0.0 111.736 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.42 12.1 4.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.162 1.385 . . . . 0.0 113.705 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -74.29 -179.73 4.08 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.938 -1.101 . . . . 0.0 112.836 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.7 11.93 8.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.466 1.506 . . . . 0.0 113.795 -163.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.406 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 37' ' ' MET . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -119.89 175.43 5.9 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 112.361 175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.28 1.3 27.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.01 -166.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -156.86 150.34 24.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.227 1.811 . . . . 0.0 110.602 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.59 18.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.016 1.326 . . . . 0.0 113.623 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -170.33 160.13 7.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.457 1.103 . . . . 0.0 112.082 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.84 25.53 1.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.926 1.29 . . . . 0.0 112.291 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -160.99 178.55 9.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.28 1.032 . . . . 0.0 112.217 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.31 10.52 27.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.414 1.485 . . . . 0.0 113.43 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -82.69 142.96 31.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.393 1.077 . . . . 0.0 111.676 172.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.46 16.8 12.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 112.031 166.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 p -77.22 148.71 35.68 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.478 1.111 . . . . 0.0 113.097 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.31 22.73 1.34 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.856 1.262 . . . . 0.0 112.655 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -83.55 -176.28 6.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.829 1.252 . . . . 0.0 113.308 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.26 8.99 38.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.56 1.544 . . . . 0.0 112.829 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -84.67 -175.35 5.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.42 18.62 15.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.245 1.818 . . . . 0.0 112.409 -168.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -68.16 173.14 4.94 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.969 -1.082 . . . . 0.0 113.245 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 11.89 3.85 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.213 1.405 . . . . 0.0 113.713 -162.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.878 0.847 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p -86.19 158.95 19.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.233 1.413 . . . . 0.0 112.789 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.18 27.83 0.84 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.798 1.239 . . . . 0.0 113.096 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HD3' ' A' ' 94' ' ' PRO . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD3' HG12 ' A' ' 40' ' ' VAL . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -162.63 154.49 18.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.018 1.727 . . . . 0.0 110.816 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.48 7.41 6.98 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -72.27 62.63 0.5 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.245 1.818 . . . . 0.0 112.412 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.77 3.88 21.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.774 1.629 . . . . 0.0 113.386 -164.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.439 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.13 0.491 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -154.09 170.82 20.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.386 1.075 . . . . 0.0 111.623 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.62 15.05 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.027 1.331 . . . . 0.0 113.155 -161.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -158.84 166.24 32.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.925 1.69 . . . . 0.0 111.448 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 13.53 4.19 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.441 1.096 . . . . 0.0 113.455 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 24' ' ' VAL . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -64.81 164.15 12.86 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.999 1.72 . . . . 0.0 113.807 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.4 26.06 1.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 113.417 -167.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 41' ' ' LEU . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.473 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.942 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.436 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.461 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.406 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 37' ' ' MET . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.419 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.432 HD22 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.904 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.409 HD21 ' HG2' ' A' ' 96' ' ' GLU . 4.3 p-10 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 93' ' ' ASN . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 121.553 0.692 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HD3' ' A' ' 94' ' ' PRO . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD3' HG12 ' A' ' 40' ' ' VAL . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.439 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.423 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.888 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 24' ' ' VAL . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 41' ' ' LEU . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.473 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -160.37 148.51 16.56 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.35 1.46 . . . . 0.0 111.335 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -147.88 24.02 1.08 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.321 1.448 . . . . 0.0 111.923 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.0 mt -70.99 91.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.912 0.885 . . . . 0.0 111.079 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.4 16.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.701 2.0 . . . . 0.0 111.068 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -46.7 126.19 8.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.416 1.886 . . . . 0.0 113.933 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.6 41.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.1 m -48.77 -33.81 11.04 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 120.785 -1.197 . . . . 0.0 114.127 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 t -77.92 -13.51 59.86 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.184 1.394 . . . . 0.0 113.715 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -120.87 12.24 11.24 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.22 1.808 . . . . 0.0 112.871 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.6 3.49 16.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.937 1.695 . . . . 0.0 115.277 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.25 39.78 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.366 0.984 . . . . 0.0 111.194 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.8 ptm -51.25 -31.35 20.61 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.256 1.022 . . . . 0.0 113.15 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.16 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.127 1.771 . . . . 0.0 115.068 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.02 -28.41 12.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.119 0.968 . . . . 0.0 112.193 170.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.69 -26.4 67.09 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.922 1.237 . . . . 0.0 112.623 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.67 -8.72 57.28 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.894 1.277 . . . . 0.0 113.211 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.92 -0.12 9.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.284 1.897 . . . . 0.0 113.525 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.06 172.83 11.64 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.629 1.215 . . . . 0.0 110.745 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 m -112.15 -41.32 3.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.681 1.193 . . . . 0.0 109.532 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -152.25 128.6 10.59 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.809 2.443 . . . . 0.0 109.252 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.56 138.35 12.01 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.915 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.7 135.1 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.916 -1.115 . . . . 0.0 110.047 171.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.34 123.55 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.042 0.937 . . . . 0.0 111.633 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.82 116.6 29.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.87 2.068 . . . . 0.0 111.316 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -90.25 135.21 33.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 110.09 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -157.63 175.07 14.4 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -145.91 145.0 30.53 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.514 1.926 . . . . 0.0 109.722 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -31.55 62.01 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.899 2.08 . . . . 0.0 114.238 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.6 mt -102.1 80.61 2.0 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.204 1.801 . . . . 0.0 108.353 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.6 t -163.01 99.0 1.04 Allowed Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.695 1.198 . . . . 0.0 112.356 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.63 -39.09 67.18 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.589 2.859 . . . . 0.0 113.317 173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -70.95 -31.94 68.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.8 m -56.45 -27.52 57.0 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.256 1.822 . . . . 0.0 113.24 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -53.99 -48.69 70.12 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.798 1.239 . . . . 0.0 112.803 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -56.49 -43.37 79.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.517 1.127 . . . . 0.0 111.664 -176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -56.4 -38.51 71.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.338 -0.839 . . . . 0.0 112.486 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.43 -44.7 82.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.209 1.368 . . . . 0.0 111.166 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -41.09 86.28 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.359 0.663 . . . . 0.0 111.79 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.7 m -87.0 -32.73 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.7 mt -68.93 -30.98 69.55 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.303 1.041 . . . . 0.0 111.975 172.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.02 -53.44 57.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.617 0.722 . . . . 0.0 111.356 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -68.55 -27.65 66.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.116 0.967 . . . . 0.0 112.685 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -67.64 -51.63 47.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.493 0.717 . . . . 0.0 111.381 170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.53 -38.75 95.41 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.462 1.03 . . . . 0.0 112.052 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.9 -21.96 66.7 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.07 -7.85 22.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.289 1.835 . . . . 0.0 113.073 173.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.69 65.38 39.21 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.737 1.615 . . . . 0.0 112.863 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -59.41 -29.64 90.64 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.582 3.521 . . . . 0.0 114.438 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -70.85 -21.55 62.42 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.08 141.07 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.763 0.825 . . . . 0.0 110.665 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.45 130.11 50.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.537 1.135 . . . . 0.0 109.699 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.6 118.44 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.9 m -112.04 176.82 4.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.02 1.328 . . . . 0.0 111.017 169.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 90.1 p -106.84 -179.88 4.07 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.735 -1.228 . . . . 0.0 111.658 163.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.7 t -143.85 129.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.489 1.916 . . . . 0.0 107.912 165.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -78.2 79.97 4.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.728 1.611 . . . . 0.0 110.771 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.3 -31.85 64.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.52 1.528 . . . . 0.0 113.037 -170.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.66 -26.98 67.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.603 1.161 . . . . 0.0 113.635 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.15 3.18 32.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.355 1.862 . . . . 0.0 112.325 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 65.62 7.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 127.186 2.195 . . . . 0.0 111.04 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.46 -18.63 20.02 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.215 3.276 . . . . 0.0 113.715 -174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -33.89 43.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.081 0.952 . . . . 0.0 111.746 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.91 -47.67 79.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.399 0.68 . . . . 0.0 111.155 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -61.12 -41.08 96.06 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.191 0.905 . . . . 0.0 111.61 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -63.23 -46.24 87.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.682 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -72.26 -30.34 64.76 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -75.26 -4.55 39.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.247 1.419 . . . . 0.0 111.921 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.21 10.99 12.67 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.852 1.691 . . . . 0.0 117.083 160.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.1 165.48 35.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.238 2.019 . . . . 0.0 114.815 -167.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.37 23.7 0.08 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.011 1.324 . . . . 0.0 113.118 -164.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -121.62 -151.9 0.49 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.907 2.083 . . . . 0.0 112.679 -160.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -49.15 160.57 0.5 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 126.73 2.012 . . . . 0.0 112.772 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -46.4 137.02 15.01 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 124.128 3.219 . . . . 0.0 113.344 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.3 m -136.98 131.75 33.38 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.377 1.071 . . . . 0.0 110.9 -165.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -98.56 119.95 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.288 1.435 . . . . 0.0 109.2 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.7 134.64 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.981 0.912 . . . . 0.0 110.408 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -122.42 121.56 36.93 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.742 2.017 . . . . 0.0 110.666 -171.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -103.69 131.02 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.149 1.78 . . . . 0.0 109.009 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -149.12 124.69 10.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.054 1.342 . . . . 0.0 110.068 174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 79.44 22.65 0.55 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.532 2.333 . . . . 0.0 113.089 173.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.12 28.52 58.24 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.92 0.771 . . . . 0.0 112.817 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -148.52 164.48 34.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.117 168.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.24 115.18 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 121.534 0.683 . . . . 0.0 109.67 171.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.92 -27.63 19.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.974 0.91 . . . . 0.0 113.057 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -152.46 147.28 26.07 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -128.92 118.66 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 127.068 2.147 . . . . 0.0 106.648 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.68 110.64 13.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.561 1.144 . . . . 0.0 111.396 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.9 p -93.97 125.74 38.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.013 1.325 . . . . 0.0 110.739 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.34 -172.27 16.09 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.046 1.308 . . . . 0.0 113.917 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.2 mm -87.02 144.63 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.658 1.183 . . . . 0.0 111.479 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -134.8 166.56 22.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.74 1.216 . . . . 0.0 112.14 171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.52 160.04 36.16 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 125.304 1.442 . . . . 0.0 110.539 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.21 -41.32 43.51 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.399 2.732 . . . . 0.0 113.229 -170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -35.92 73.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.141 1.377 . . . . 0.0 111.91 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -81.5 -32.19 32.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.81 1.244 . . . . 0.0 111.954 175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -46.34 86.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.492 1.117 . . . . 0.0 110.817 170.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.62 -46.92 83.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.901 1.68 . . . . 0.0 111.531 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.23 -46.88 72.46 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.388 0.675 . . . . 0.0 112.777 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.66 -52.16 64.79 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.74 1.616 . . . . 0.0 110.199 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.04 -53.58 56.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.725 0.81 . . . . 0.0 112.841 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 -27.18 67.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.619 0.768 . . . . 0.0 112.455 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -76.39 -10.44 59.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 112.766 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 79.5 mt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 125.22 1.408 . . . . 0.0 109.291 174.208 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 52.17 -103.19 0.15 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.833 1.653 . . . . 0.0 112.599 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.13 -0.8 22.55 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.074 1.35 . . . . 0.0 113.05 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.5 mt -69.21 94.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.258 1.423 . . . . 0.0 110.242 -169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 150.27 36.44 Favored 'General case' 0 C--O 1.216 -0.66 0 C-N-CA 126.497 1.919 . . . . 0.0 107.042 166.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.47 101.06 2.34 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 127.355 2.262 . . . . 0.0 110.553 169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 pt -98.6 36.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.588 1.155 . . . . 0.0 111.701 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.4 m -45.2 -31.72 1.6 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.814 2.446 . . . . 0.0 114.561 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 t -105.13 -6.46 19.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.857 1.663 . . . . 0.0 114.652 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -118.47 16.53 13.81 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.439 1.496 . . . . 0.0 112.941 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.95 30.94 5.7 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.34 1.456 . . . . 0.0 114.008 167.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 146.46 35.75 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.742 1.163 . . . . 0.0 112.303 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -53.23 -31.52 43.67 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.2 -52.3 59.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.23 1.812 . . . . 0.0 113.407 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.57 -29.88 20.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.771 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -59.97 -27.96 67.27 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.909 1.231 . . . . 0.0 113.677 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.97 -7.24 53.06 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.413 1.085 . . . . 0.0 112.983 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.1 0.47 11.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.456 1.979 . . . . 0.0 114.038 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.04 178.22 6.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.345 1.073 . . . . 0.0 111.762 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -124.87 -35.58 2.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.508 1.123 . . . . 0.0 110.836 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -145.42 148.47 33.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.974 2.51 . . . . 0.0 107.919 169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.1 136.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 110.138 164.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.55 133.19 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 O-C-N 120.635 -1.291 . . . . 0.0 109.023 166.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.77 127.95 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 123.809 0.844 . . . . 0.0 111.525 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.87 117.74 35.28 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.066 1.746 . . . . 0.0 110.797 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -88.37 127.12 35.49 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.529 1.531 . . . . 0.0 110.885 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -147.94 161.52 41.16 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.531 0.732 . . . . 0.0 112.237 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -124.03 149.1 46.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.787 2.035 . . . . 0.0 109.298 174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -34.98 69.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.338 1.855 . . . . 0.0 114.151 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.1 mt -97.68 73.82 2.36 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.825 2.05 . . . . 0.0 109.56 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -156.31 112.65 2.07 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.023 0.929 . . . . 0.0 112.132 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.36 -35.41 2.24 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.962 2.441 . . . . 0.0 112.382 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -68.6 -33.11 73.48 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.9 m -56.43 -30.0 62.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.462 1.505 . . . . 0.0 113.718 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -60.33 -40.18 89.71 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.024 0.93 . . . . 0.0 112.263 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -58.14 -38.37 76.44 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.218 -0.926 . . . . 0.0 111.807 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -64.84 -50.96 64.62 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 111.173 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.93 -28.51 69.88 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.749 1.159 . . . . 0.0 112.803 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -30.69 71.74 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.6 m -104.26 -29.62 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.58 -34.97 78.1 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.561 1.544 . . . . 0.0 110.889 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -57.99 -56.34 23.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.573 0.702 . . . . 0.0 111.652 169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -65.84 -26.62 67.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.681 0.792 . . . . 0.0 113.133 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.77 -52.4 37.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.618 0.767 . . . . 0.0 111.141 168.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.23 -36.84 93.03 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.168 0.889 . . . . 0.0 113.03 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.37 68.15 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.873 1.269 . . . . 0.0 113.416 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 -10.03 23.96 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.221 1.808 . . . . 0.0 113.144 174.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.8 66.2 47.8 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.295 1.838 . . . . 0.0 112.371 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.95 -28.59 86.56 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.445 3.43 . . . . 0.0 114.438 -172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.36 -21.12 61.35 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.14 138.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.594 0.758 . . . . 0.0 110.212 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.34 120.56 40.13 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.39 1.076 . . . . 0.0 109.46 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.38 120.73 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.071 0.949 . . . . 0.0 109.375 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.8 m -122.97 168.14 12.69 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.628 1.571 . . . . 0.0 110.589 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.8 p -100.33 164.6 11.86 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.011 -1.68 . . . . 0.0 112.765 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.56 129.56 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.616 1.566 . . . . 0.0 109.218 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.63 95.56 0.87 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.866 0.866 . . . . 0.0 109.3 168.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.9 p -63.08 -28.33 70.0 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.244 -0.91 . . . . 0.0 111.88 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.39 -24.27 66.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.171 1.388 . . . . 0.0 114.38 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.436 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -86.05 -10.37 55.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.727 0.694 . . . . 0.0 111.719 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.36 70.38 4.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.931 1.692 . . . . 0.0 112.46 -177.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.76 -25.36 46.2 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.28 2.653 . . . . 0.0 112.625 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.1 -34.92 69.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.994 0.918 . . . . 0.0 112.588 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.58 -51.57 62.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.349 0.66 . . . . 0.0 109.254 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -59.61 -38.77 82.19 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.496 0.589 . . . . 0.0 112.381 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -58.87 -52.63 64.91 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.016 0.926 . . . . 0.0 111.319 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -68.2 -25.95 65.48 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 tp -77.27 -7.59 56.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.367 1.467 . . . . 0.0 112.648 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.03 12.04 10.39 Favored Glycine 0 C--N 1.343 0.956 0 C-N-CA 125.46 1.505 . . . . 0.0 116.801 164.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -154.5 159.19 40.84 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 120.219 2.01 . . . . 0.0 114.949 -171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.44 28.92 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.701 1.6 . . . . 0.0 111.913 -164.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -130.84 -150.47 0.43 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.689 1.996 . . . . 0.0 112.039 -162.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.6 m -48.02 155.41 0.87 Allowed Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 126.222 1.809 . . . . 0.0 112.661 168.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -53.46 144.61 50.16 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.678 2.919 . . . . 0.0 112.951 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.7 m -139.43 140.35 37.33 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.24 1.016 . . . . 0.0 111.796 -159.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -100.54 137.69 38.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.905 1.682 . . . . 0.0 108.802 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.92 135.49 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.598 1.159 . . . . 0.0 110.126 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -117.42 128.3 54.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.289 1.836 . . . . 0.0 110.563 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -112.67 141.31 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 127.045 2.138 . . . . 0.0 109.931 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -153.7 120.55 5.65 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.459 1.904 . . . . 0.0 109.27 -170.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.15 25.46 7.21 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.091 1.356 . . . . 0.0 114.417 174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.23 22.52 40.94 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.705 1.145 . . . . 0.0 114.358 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.63 167.0 23.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.32 1.448 . . . . 0.0 112.218 172.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.57 118.23 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.11 -38.7 35.56 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.226 1.01 . . . . 0.0 112.86 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.61 146.83 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -171.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.4 t -121.97 128.92 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.273 1.829 . . . . 0.0 107.237 164.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -132.07 109.49 10.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 0.0 110.763 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.7 p -95.28 123.25 38.7 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.734 1.213 . . . . 0.0 111.139 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 125.38 -171.75 17.34 Favored Glycine 0 N--CA 1.471 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.136 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.24 138.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.044 0.938 . . . . 0.0 111.419 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.1 mmt -113.67 168.73 9.53 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.913 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.57 155.75 81.03 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.527 1.131 . . . . 0.0 110.159 159.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.38 -38.36 54.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.922 2.415 . . . . 0.0 112.821 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.58 -36.12 71.29 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.498 1.519 . . . . 0.0 112.656 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -83.07 -31.98 27.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.683 1.193 . . . . 0.0 111.914 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -43.52 97.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.856 0.862 . . . . 0.0 110.965 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.6 -47.02 83.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.55 1.54 . . . . 0.0 111.399 173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.08 75.36 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.95 -48.62 77.91 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.339 1.056 . . . . 0.0 111.108 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.69 -51.81 66.89 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.619 0.767 . . . . 0.0 112.674 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.17 -27.99 67.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.565 0.746 . . . . 0.0 112.014 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 m -80.07 -8.06 59.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.462 1.105 . . . . 0.0 113.721 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.408 1.483 . . . . 0.0 109.499 172.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.019 0.437 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 82.8 p -83.48 178.88 7.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.428 1.091 . . . . 0.0 112.999 173.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.96 14.1 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.602 1.161 . . . . 0.0 113.834 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.9 mt -66.09 99.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.845 1.258 . . . . 0.0 111.382 -163.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 150.03 30.35 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 127.046 2.138 . . . . 0.0 108.338 169.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.39 95.26 0.6 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 126.747 2.019 . . . . 0.0 110.772 163.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.64 24.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.048 1.339 . . . . 0.0 113.457 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m -39.29 -35.06 0.23 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.181 2.592 . . . . 0.0 114.745 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -90.63 -22.34 21.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.668 1.987 . . . . 0.0 114.123 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -124.63 23.96 7.93 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.151 1.38 . . . . 0.0 112.935 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.3 26.02 11.14 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.972 1.709 . . . . 0.0 113.486 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.65 146.78 39.21 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.869 1.223 . . . . 0.0 112.051 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.6 ptp -52.09 -32.03 33.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.307 1.043 . . . . 0.0 113.284 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.4 40.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.701 2.0 . . . . 0.0 113.673 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.78 -28.01 18.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.698 0.799 . . . . 0.0 112.102 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -62.92 -23.3 67.3 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.124 0.969 . . . . 0.0 113.397 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -73.57 -8.37 55.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 113.351 168.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.6 0.02 9.33 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.281 1.896 . . . . 0.0 113.957 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -78.05 174.75 10.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.257 1.028 . . . . 0.0 111.389 175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -115.57 -36.27 4.31 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.091 1.356 . . . . 0.0 110.688 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -160.04 118.97 2.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.667 2.387 . . . . 0.0 108.428 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.71 138.24 14.02 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 112.152 175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.89 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 120.289 -1.507 . . . . 0.0 109.615 170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.25 120.98 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.241 1.017 . . . . 0.0 111.032 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -94.86 112.84 24.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.847 1.659 . . . . 0.0 110.071 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -85.55 129.11 34.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.408 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.93 163.68 36.74 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.727 0.811 . . . . 0.0 111.792 -171.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -124.31 148.77 47.21 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.354 1.862 . . . . 0.0 109.301 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -34.75 68.08 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.116 1.767 . . . . 0.0 113.67 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.55 77.77 2.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.445 1.898 . . . . 0.0 109.35 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.0 t -156.67 109.15 1.99 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 123.95 0.9 . . . . 0.0 112.165 -171.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.43 -32.1 4.07 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.295 2.663 . . . . 0.0 112.075 174.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -66.84 -37.93 85.43 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -53.83 -31.6 49.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 113.607 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -52.41 -43.9 65.07 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.719 1.208 . . . . 0.0 113.237 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -66.88 -31.72 72.51 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 120.649 -1.282 . . . . 0.0 112.086 -172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -67.98 -53.03 29.14 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.676 1.19 . . . . 0.0 111.078 173.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.69 -26.98 68.93 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 112.706 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -26.89 68.96 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.2 m -110.89 -29.07 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.354 1.062 . . . . 0.0 113.772 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.15 -34.96 79.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.42 1.488 . . . . 0.0 111.114 170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.19 -56.47 21.68 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.682 0.753 . . . . 0.0 111.862 171.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.81 -27.87 67.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.234 1.014 . . . . 0.0 112.585 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -69.25 -50.18 49.48 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.782 0.833 . . . . 0.0 111.074 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.53 -38.56 96.56 Favored Glycine 0 N--CA 1.469 0.836 0 CA-C-N 118.868 0.758 . . . . 0.0 112.949 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.93 -23.25 65.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -9.92 19.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.036 1.735 . . . . 0.0 113.204 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 60.76 53.01 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 125.038 1.335 . . . . 0.0 112.412 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -61.72 -29.6 83.75 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.411 3.408 . . . . 0.0 113.838 -167.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.79 -18.88 61.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -102.41 141.52 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.789 0.836 . . . . 0.0 110.6 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.86 128.0 47.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.081 0.952 . . . . 0.0 109.411 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.61 132.83 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.532 1.133 . . . . 0.0 108.515 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 m -149.83 157.67 43.42 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.148 0.979 . . . . 0.0 111.592 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 p -89.84 156.82 18.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.849 -1.157 . . . . 0.0 112.181 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 76.8 t -131.15 130.92 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.726 1.21 . . . . 0.0 109.018 169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -72.23 94.37 1.56 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.541 0.736 . . . . 0.0 109.671 172.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.6 p -62.2 -27.29 68.87 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.17 -0.956 . . . . 0.0 111.831 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.12 -23.71 64.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.65 1.58 . . . . 0.0 114.167 171.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.461 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -89.69 -12.1 40.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.849 0.86 . . . . 0.0 112.443 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.23 70.65 6.93 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.708 2.003 . . . . 0.0 111.251 -178.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.7 -21.89 44.49 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.095 2.53 . . . . 0.0 112.17 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.88 -34.48 73.62 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.071 0.948 . . . . 0.0 112.279 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.4 tp -67.74 -46.79 71.13 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.777 -0.577 . . . . 0.0 110.619 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -61.49 -38.26 86.65 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.626 0.648 . . . . 0.0 112.215 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.46 -50.31 74.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.502 0.721 . . . . 0.0 111.682 174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.73 -26.4 65.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -72.64 -12.18 60.94 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.257 1.023 . . . . 0.0 112.833 168.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.48 21.38 19.69 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.524 1.535 . . . . 0.0 115.118 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -141.02 157.24 45.61 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.726 1.263 . . . . 0.0 113.435 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.43 38.62 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.998 1.319 . . . . 0.0 112.004 -162.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -148.35 -150.89 0.36 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.72 1.208 . . . . 0.0 111.778 -153.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.0 m -46.41 155.28 0.58 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 125.909 1.684 . . . . 0.0 112.886 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -54.74 148.28 46.14 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.297 2.665 . . . . 0.0 113.102 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.1 m -145.21 141.29 28.54 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.141 0.977 . . . . 0.0 111.534 -159.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 mt -99.03 140.66 32.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.486 1.515 . . . . 0.0 109.487 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -130.41 136.19 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.712 1.205 . . . . 0.0 109.393 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -118.4 124.48 47.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.809 1.644 . . . . 0.0 110.372 -171.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.21 134.5 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.56 1.944 . . . . 0.0 108.77 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -151.59 127.88 10.58 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.221 1.808 . . . . 0.0 108.772 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 72.76 17.79 4.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.116 1.766 . . . . 0.0 113.832 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.42 24.75 42.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.2 0.905 . . . . 0.0 112.734 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 166.77 30.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.972 0.909 . . . . 0.0 112.907 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.32 119.12 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.635 -0.666 . . . . 0.0 109.592 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.71 -30.91 18.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.167 1.387 . . . . 0.0 113.572 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -154.74 147.37 24.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.4 t -123.52 132.04 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.099 1.76 . . . . 0.0 107.521 164.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.21 106.46 7.59 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.863 1.265 . . . . 0.0 110.185 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.5 p -98.85 129.29 45.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.701 1.2 . . . . 0.0 111.086 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.71 -167.42 13.88 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.334 1.445 . . . . 0.0 113.56 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 mm -99.29 149.71 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.212 1.405 . . . . 0.0 111.089 -171.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.33 164.69 37.68 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.59 157.56 33.44 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 128.556 2.743 . . . . 0.0 110.033 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.64 -39.54 20.65 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.05 1.833 . . . . 0.0 112.794 -166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.28 -31.8 67.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 0.0 112.745 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -74.94 -32.42 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.376 0.671 . . . . 0.0 111.869 173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -45.2 95.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.967 0.803 . . . . 0.0 111.631 169.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -45.91 85.58 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.2 1.0 . . . . 0.0 111.492 172.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.49 -47.34 73.35 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.1 mt -55.4 -50.99 68.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.3 1.04 . . . . 0.0 110.015 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -62.87 -53.23 57.33 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.51 -28.67 67.26 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 123.531 0.732 . . . . 0.0 111.959 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.8 p -72.91 -21.23 60.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 124.851 1.26 . . . . 0.0 109.477 177.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.7 p -115.21 -162.23 0.82 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.791 1.636 . . . . 0.0 111.736 171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.42 12.1 4.53 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.162 1.385 . . . . 0.0 113.705 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.92 98.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.898 1.279 . . . . 0.0 111.071 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -119.46 148.28 43.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.742 2.017 . . . . 0.0 108.716 169.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -67.12 92.94 0.27 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 126.751 2.02 . . . . 0.0 110.607 168.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -86.95 29.51 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.109 1.364 . . . . 0.0 112.357 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.0 m -42.64 -36.2 1.33 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.158 2.183 . . . . 0.0 114.226 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -98.76 -9.09 24.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.808 1.643 . . . . 0.0 114.597 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -115.62 16.37 16.49 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 126.032 1.733 . . . . 0.0 112.373 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.59 7.87 30.94 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.53 144.17 48.78 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.189 0.9 . . . . 0.0 112.398 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.9 ptm -50.34 -32.13 16.4 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 113.28 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.19 -54.37 21.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.618 1.967 . . . . 0.0 113.56 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.53 -25.21 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.057 -0.973 . . . . 0.0 112.477 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -60.29 -26.19 66.32 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.247 1.385 . . . . 0.0 113.35 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -78.29 -3.17 41.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.604 1.162 . . . . 0.0 112.843 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.48 -2.48 9.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 126.52 2.01 . . . . 0.0 113.814 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.37 169.56 17.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.44 1.096 . . . . 0.0 110.867 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.5 m -114.19 -34.03 5.48 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.786 0.834 . . . . 0.0 111.433 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -166.79 107.09 0.64 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.365 1.866 . . . . 0.0 107.965 -167.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . . . -147.53 128.52 14.52 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.996 0.919 . . . . 0.0 111.149 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -107.58 131.33 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.952 -1.092 . . . . 0.0 108.063 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.82 110.05 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -162.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.27 112.87 25.49 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.24 1.016 . . . . 0.0 111.847 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.24 129.37 37.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.876 1.67 . . . . 0.0 110.892 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -150.97 169.02 22.78 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.952 0.901 . . . . 0.0 112.676 -171.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -128.78 149.55 50.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.601 1.961 . . . . 0.0 109.54 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -32.32 66.53 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.457 1.903 . . . . 0.0 114.021 175.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.26 71.99 3.87 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.344 1.858 . . . . 0.0 108.789 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.3 t -160.72 111.91 1.32 Allowed Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.764 0.826 . . . . 0.0 112.6 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.6 -32.02 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.577 2.852 . . . . 0.0 112.307 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -72.71 -29.47 63.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.0 m -55.52 -29.46 58.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.029 1.732 . . . . 0.0 113.024 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -50.16 -46.13 53.86 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.403 1.481 . . . . 0.0 112.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.28 -36.48 81.63 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.981 -1.075 . . . . 0.0 111.763 -170.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -59.37 -38.28 80.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.42 1.088 . . . . 0.0 112.004 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -66.15 -44.54 83.84 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.431 1.014 . . . . 0.0 110.414 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -42.14 99.28 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.072 0.549 . . . . 0.0 111.861 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -78.8 -33.57 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.4 mt -67.64 -30.72 70.36 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 112.817 171.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.32 -49.13 68.06 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.663 0.744 . . . . 0.0 111.088 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -70.4 -24.48 62.94 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.845 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -69.31 -50.39 47.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 111.26 164.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.69 -32.4 81.44 Favored Glycine 0 N--CA 1.471 1.029 0 C-N-CA 125.038 1.304 . . . . 0.0 113.462 -176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.04 -29.77 65.63 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.202 1.401 . . . . 0.0 113.449 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.97 -11.56 16.13 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.84 72.42 32.26 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.785 1.634 . . . . 0.0 111.619 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.49 -31.38 13.82 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.918 3.079 . . . . 0.0 113.433 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -72.89 -19.4 61.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.2 p -98.58 140.73 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.337 1.055 . . . . 0.0 110.034 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.46 113.65 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.64 0.776 . . . . 0.0 109.216 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.8 125.95 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 m -135.9 163.85 29.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.889 1.276 . . . . 0.0 110.536 173.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.7 p -103.86 167.13 9.98 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 120.52 -1.363 . . . . 0.0 113.152 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.7 t -140.42 135.48 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.932 1.693 . . . . 0.0 110.993 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -73.67 95.38 2.33 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 165.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.3 p -61.96 -29.79 70.48 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.459 -0.776 . . . . 0.0 112.323 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -59.43 -26.47 65.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.81 1.644 . . . . 0.0 114.175 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -84.33 -11.89 55.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.008 0.822 . . . . 0.0 111.488 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -156.13 71.88 5.13 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.852 1.661 . . . . 0.0 111.561 -175.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.67 -23.56 48.9 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.191 2.594 . . . . 0.0 112.479 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.8 -34.2 69.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.194 0.998 . . . . 0.0 112.389 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.3 tp -64.38 -51.17 64.59 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 118.92 -0.562 . . . . 0.0 110.066 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ptt? -60.58 -38.39 84.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.734 0.697 . . . . 0.0 111.744 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -60.09 -48.65 80.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.495 0.718 . . . . 0.0 111.619 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -71.44 -28.37 63.92 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.59 -6.43 55.55 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.571 1.548 . . . . 0.0 112.612 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.98 16.04 9.48 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.131 1.613 . . . . 0.0 117.131 164.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -152.18 165.46 34.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.157 1.979 . . . . 0.0 113.919 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -165.27 43.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.413 1.085 . . . . 0.0 112.741 -162.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -154.04 -158.15 0.84 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.27 1.028 . . . . 0.0 112.68 -152.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 m -52.69 161.9 1.06 Allowed Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 127.878 2.471 . . . . 0.0 112.75 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.01 141.38 37.33 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.126 3.217 . . . . 0.0 113.087 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -141.59 135.35 29.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.806 0.812 . . . . 0.0 112.442 -160.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.9 mt -93.33 120.32 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.36 1.864 . . . . 0.0 109.004 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.71 136.77 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.445 1.098 . . . . 0.0 110.058 173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -112.05 114.64 27.63 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.626 1.571 . . . . 0.0 109.521 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mm -100.54 137.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.788 2.035 . . . . 0.0 108.992 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -159.74 124.7 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.182 1.393 . . . . 0.0 109.231 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t70 67.1 21.63 10.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.256 1.822 . . . . 0.0 113.506 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.41 26.71 58.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.349 1.452 . . . . 0.0 112.837 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -140.04 162.66 34.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.506 1.122 . . . . 0.0 112.47 169.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.5 117.44 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.623 -0.673 . . . . 0.0 109.486 169.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.53 -28.81 19.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.802 0.841 . . . . 0.0 113.216 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.51 148.14 19.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.975 0.91 . . . . 0.0 112.499 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -133.65 125.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.529 1.532 . . . . 0.0 107.706 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -128.31 118.54 23.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.904 1.282 . . . . 0.0 110.752 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 p -100.01 125.88 46.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.733 1.213 . . . . 0.0 111.877 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.59 -164.89 17.84 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.445 1.497 . . . . 0.0 113.791 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 mm -90.16 145.49 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.716 1.206 . . . . 0.0 111.454 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mmt -133.97 168.29 19.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.347 1.459 . . . . 0.0 113.021 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.23 157.62 71.84 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.831 1.252 . . . . 0.0 110.8 170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.83 -37.37 45.41 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.517 2.811 . . . . 0.0 113.564 -169.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 mmp_? -55.22 -37.16 66.79 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.862 1.265 . . . . 0.0 112.458 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -87.2 -29.68 21.56 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.061 1.344 . . . . 0.0 112.004 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -44.46 89.13 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.113 0.965 . . . . 0.0 110.497 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -57.31 -43.78 83.59 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.554 1.142 . . . . 0.0 112.176 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.38 -45.21 69.84 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.62 -51.02 70.26 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.746 1.218 . . . . 0.0 110.647 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -61.32 -55.17 34.71 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.908 0.883 . . . . 0.0 113.227 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.03 66.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.931 0.492 . . . . 0.0 111.493 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -72.32 -21.29 61.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 125.396 1.478 . . . . 0.0 111.14 -179.759 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -74.29 -179.73 4.08 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.938 -1.101 . . . . 0.0 112.836 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -124.7 11.93 8.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.466 1.506 . . . . 0.0 113.795 -163.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.55 120.21 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.662 1.985 . . . . 0.0 113.262 -166.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 179.07 3.82 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 131.02 3.728 . . . . 0.0 110.312 159.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.8 136.84 55.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.003 2.921 . . . . 0.0 114.409 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.7 24.03 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 171.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.4 m -40.44 -41.58 1.44 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -82.21 -18.58 42.12 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 114.248 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -110.93 11.9 22.23 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.564 1.946 . . . . 0.0 112.734 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.35 8.38 19.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.09 145.61 41.53 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.881 0.753 . . . . 0.0 111.559 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptm -52.0 -29.84 22.54 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.508 1.123 . . . . 0.0 113.683 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 -37.22 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.476 1.91 . . . . 0.0 115.356 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -27.79 13.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.513 0.725 . . . . 0.0 112.353 171.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -62.12 -23.06 66.32 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.021 0.828 . . . . 0.0 113.033 174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.91 -8.76 57.67 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.573 1.149 . . . . 0.0 113.215 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.89 -0.45 9.05 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.194 1.854 . . . . 0.0 113.632 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.2 mt -73.31 174.67 7.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.272 1.036 . . . . 0.0 111.664 173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -115.56 -41.62 3.23 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.47 -0.769 . . . . 0.0 109.473 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -151.14 129.31 11.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.644 1.977 . . . . 0.0 109.96 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.54 143.2 17.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.552 1.141 . . . . 0.0 111.68 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.9 mt -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.479 1.111 . . . . 0.0 109.674 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.2 122.43 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 123.19 0.596 . . . . 0.0 111.079 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -97.63 123.91 41.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.007 1.323 . . . . 0.0 110.112 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -102.12 129.0 48.36 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.678 1.191 . . . . 0.0 110.179 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 160.88 41.75 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 121.547 0.689 . . . . 0.0 112.551 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 39.9 ttpt -119.2 149.02 42.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.801 2.04 . . . . 0.0 109.209 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -31.55 66.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.096 1.759 . . . . 0.0 114.306 174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 24.8 mt -94.59 72.74 3.69 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.59 1.956 . . . . 0.0 108.389 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.0 t -160.66 111.26 1.33 Allowed Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.435 1.094 . . . . 0.0 112.065 -172.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.01 -33.14 2.22 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.825 2.35 . . . . 0.0 112.117 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -72.97 -28.75 62.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 87.5 m -56.95 -25.79 58.5 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.217 1.807 . . . . 0.0 113.795 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -50.13 -47.47 54.05 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.072 1.349 . . . . 0.0 112.588 171.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -66.01 -36.22 82.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.842 -1.161 . . . . 0.0 111.69 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.406 ' HA ' HG22 ' A' ' 40' ' ' VAL . 4.0 mpp? -62.66 -26.67 68.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 113.294 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -72.03 -46.12 58.28 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.212 1.369 . . . . 0.0 110.362 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -42.26 97.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.127 0.571 . . . . 0.0 111.786 -175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 37' ' ' MET . 35.9 m -68.92 -40.34 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.4 -26.17 61.76 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.18 0.992 . . . . 0.0 113.111 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.65 -54.2 30.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.847 0.832 . . . . 0.0 110.535 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.77 -22.84 61.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.807 0.843 . . . . 0.0 112.512 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -77.03 -51.2 11.49 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 111.842 170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.91 -36.44 93.09 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 119.074 0.852 . . . . 0.0 112.982 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.3 -23.29 64.06 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 170.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.98 -7.2 19.41 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.529 1.932 . . . . 0.0 113.209 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.76 68.26 58.57 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.3 1.44 . . . . 0.0 113.114 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.54 -29.95 85.44 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.833 3.689 . . . . 0.0 114.238 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.89 -20.47 62.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.3 p -104.51 137.66 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.353 1.061 . . . . 0.0 110.122 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.59 122.6 38.5 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.808 0.843 . . . . 0.0 109.382 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.6 130.69 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.424 0.689 . . . . 0.0 110.686 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 m -132.36 162.03 32.09 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.834 1.254 . . . . 0.0 112.231 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.3 t -131.93 132.23 43.37 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.029 -1.044 . . . . 0.0 113.089 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.0 t -118.37 133.02 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 127.996 2.518 . . . . 0.0 111.605 -171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.63 89.81 2.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.41 1.484 . . . . 0.0 110.457 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -59.5 -32.69 70.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.828 0.851 . . . . 0.0 112.542 -175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.21 -27.44 63.91 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.437 1.495 . . . . 0.0 114.08 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.47 1.61 41.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.831 1.252 . . . . 0.0 111.987 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -155.0 67.24 5.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.578 1.951 . . . . 0.0 111.834 175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.07 -18.25 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.95 3.1 . . . . 0.0 113.851 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -32.25 39.65 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.324 0.966 . . . . 0.0 112.207 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.63 -48.95 78.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.23 0.612 . . . . 0.0 110.651 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -63.71 -37.35 87.04 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.43 -50.82 72.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.83 0.741 . . . . 0.0 111.033 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -66.66 -27.06 67.37 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -79.62 -6.06 56.32 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.836 1.254 . . . . 0.0 113.0 171.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.77 11.5 10.2 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-O 117.714 -1.603 . . . . 0.0 117.057 164.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -154.38 163.21 40.51 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.647 2.223 . . . . 0.0 114.117 -171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.75 47.94 0.23 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.782 1.233 . . . . 0.0 111.782 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -152.11 -155.29 0.6 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 112.637 -157.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 m -47.48 152.66 1.14 Allowed Pre-proline 0 N--CA 1.481 1.103 0 C-N-CA 126.93 2.092 . . . . 0.0 113.387 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -60.04 152.33 65.86 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 124.08 3.187 . . . . 0.0 112.247 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -162.25 151.59 15.76 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -163.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.86 108.12 19.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 109.1 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -88.4 127.89 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.208 1.003 . . . . 0.0 109.329 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.21 122.74 48.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -104.2 131.83 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.209 1.803 . . . . 0.0 108.103 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -145.99 124.51 12.44 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.197 1.399 . . . . 0.0 110.072 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.9 t0 73.56 21.75 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.575 1.95 . . . . 0.0 113.332 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.78 25.28 50.47 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.267 0.937 . . . . 0.0 113.484 -175.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -145.59 162.45 37.45 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 118.383 1.091 . . . . 0.0 112.717 169.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.1 115.78 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.31 -29.54 21.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.515 1.126 . . . . 0.0 113.464 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -154.59 148.26 25.35 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.374 0.669 . . . . 0.0 112.599 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.77 97.83 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.71 1.604 . . . . 0.0 107.029 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -99.67 101.89 13.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.448 1.099 . . . . 0.0 111.344 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -91.64 45.04 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.165 1.786 . . . . 0.0 112.883 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.31 179.21 18.92 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.34 1.448 . . . . 0.0 114.813 -168.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.4 mm -109.22 143.28 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.066 1.747 . . . . 0.0 110.289 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.0 mtt -139.78 171.69 13.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.663 1.585 . . . . 0.0 113.893 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.93 162.12 21.35 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.862 1.265 . . . . 0.0 109.106 153.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -57.65 -39.28 89.23 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.905 2.403 . . . . 0.0 113.115 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -57.62 -33.74 68.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.102 0.961 . . . . 0.0 113.092 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -76.66 -32.66 58.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.651 0.781 . . . . 0.0 111.274 174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.52 -44.11 97.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.381 1.072 . . . . 0.0 111.098 171.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.13 -47.01 82.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.796 1.238 . . . . 0.0 111.349 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.75 -45.27 79.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.677 0.791 . . . . 0.0 112.958 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.8 -47.49 82.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.921 1.288 . . . . 0.0 111.015 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -64.76 -53.71 42.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.166 0.586 . . . . 0.0 112.366 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.0 63.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.258 0.623 . . . . 0.0 111.916 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.9 m -71.3 -21.69 62.04 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.701 0.8 . . . . 0.0 112.758 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.954 1.302 . . . . 0.0 110.782 178.188 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtm . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -119.89 175.43 5.9 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 112.361 175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.28 1.3 27.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.381 1.472 . . . . 0.0 113.01 -166.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.9 mt -60.7 92.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.586 1.954 . . . . 0.0 110.907 -169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.23 158.41 24.36 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 126.928 2.091 . . . . 0.0 105.836 165.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.6 122.21 18.63 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 126.49 1.916 . . . . 0.0 111.667 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.8 pt -114.96 32.13 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.153 1.781 . . . . 0.0 111.573 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.8 m -46.04 -31.94 2.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.053 2.141 . . . . 0.0 114.282 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.1 t -103.7 -8.01 20.23 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.293 1.837 . . . . 0.0 113.997 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -117.41 12.67 14.3 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.807 1.643 . . . . 0.0 112.913 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.79 14.98 24.99 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 172.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.97 141.54 39.98 Favored Glycine 0 CA--C 1.528 0.862 0 O-C-N 121.055 -1.028 . . . . 0.0 111.072 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.65 -30.13 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.74 1.216 . . . . 0.0 113.604 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.52 74.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.688 1.995 . . . . 0.0 115.875 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -105.23 -25.1 12.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.908 0.776 . . . . 0.0 111.34 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -29.41 65.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.284 1.034 . . . . 0.0 112.331 171.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.13 -8.05 55.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.967 1.307 . . . . 0.0 113.293 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.99 0.7 19.61 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.451 1.977 . . . . 0.0 113.614 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.29 -178.93 4.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.439 1.12 . . . . 0.0 112.436 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.3 t -126.64 -33.79 2.49 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.036 1.335 . . . . 0.0 110.827 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -152.3 153.39 33.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.146 2.578 . . . . 0.0 109.373 164.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -168.15 141.18 3.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.459 1.503 . . . . 0.0 110.396 166.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.9 mt -112.84 131.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 163.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 p -136.02 130.13 48.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.656 0.741 . . . . 0.0 111.956 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -109.4 116.8 32.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.663 1.585 . . . . 0.0 111.335 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -90.51 132.61 35.58 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.398 1.479 . . . . 0.0 111.087 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.65 171.05 20.82 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.789 1.236 . . . . 0.0 111.08 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -130.93 179.26 6.09 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.903 -1.123 . . . . 0.0 111.907 167.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.432 HD22 ' H ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER -69.09 -35.82 76.9 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.02 2.128 . . . . 0.0 114.044 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.56 76.97 1.57 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.046 1.738 . . . . 0.0 109.305 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -157.36 110.77 1.87 Allowed Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.961 0.904 . . . . 0.0 111.931 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.25 -32.37 2.42 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.232 2.622 . . . . 0.0 112.631 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -68.89 -36.68 78.34 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.44 -0.788 . . . . 0.0 112.445 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.0 m -53.95 -30.0 44.9 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.489 1.915 . . . . 0.0 113.249 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -49.84 -47.29 51.68 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.741 1.216 . . . . 0.0 112.823 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 22.6 m-80 -65.24 -36.9 85.57 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.983 1.313 . . . . 0.0 111.652 -171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.81 -37.94 80.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.324 1.05 . . . . 0.0 112.444 173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -64.88 -43.46 92.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.524 1.056 . . . . 0.0 110.715 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -62.19 -44.67 96.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.944 0.497 . . . . 0.0 111.709 -179.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 m -74.31 -34.2 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 81.6 mt -70.78 -26.12 63.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 112.492 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.76 -54.32 23.98 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.478 0.711 . . . . 0.0 110.965 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -61.17 -32.63 72.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.877 0.871 . . . . 0.0 112.398 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -70.57 -50.63 35.32 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.944 0.898 . . . . 0.0 111.395 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.15 -33.96 88.63 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-N 119.325 0.966 . . . . 0.0 112.891 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.28 -24.17 67.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.617 1.167 . . . . 0.0 114.095 170.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 -17.33 16.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.604 1.561 . . . . 0.0 113.125 175.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.52 55.97 17.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.611 1.564 . . . . 0.0 112.76 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.27 -29.01 88.02 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.71 3.607 . . . . 0.0 114.644 -166.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.5 -19.41 60.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.1 t -85.21 131.12 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.169 1.388 . . . . 0.0 108.147 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.63 101.8 14.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.12 127.56 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.4 m -144.67 161.74 38.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.545 1.138 . . . . 0.0 111.092 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 88.6 p -98.2 163.44 12.73 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 120.236 -1.54 . . . . 0.0 112.389 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.5 t -134.19 134.89 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.414 1.486 . . . . 0.0 110.16 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -73.15 94.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.954 0.902 . . . . 0.0 110.043 165.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.2 p -62.28 -27.69 69.2 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.213 -0.929 . . . . 0.0 111.992 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.63 -24.86 65.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.822 1.249 . . . . 0.0 114.309 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -85.18 -10.91 56.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.848 0.749 . . . . 0.0 111.98 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -159.21 70.84 3.45 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 126.663 1.985 . . . . 0.0 111.923 -175.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.32 -25.84 49.12 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.373 2.715 . . . . 0.0 112.123 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.4 -35.2 70.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 112.25 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.2 tp -64.57 -49.73 70.05 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.181 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.9 ptt? -61.54 -39.57 91.56 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.507 0.594 . . . . 0.0 111.819 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -57.86 -52.48 65.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 111.671 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -69.25 -25.07 64.1 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.29 -6.34 56.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.363 1.465 . . . . 0.0 112.552 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.93 22.76 6.76 Favored Glycine 0 C--N 1.344 0.993 0 C-N-CA 125.404 1.478 . . . . 0.0 116.367 162.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -161.37 156.66 24.13 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.407 1.604 . . . . 0.0 112.663 -173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.43 33.12 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.421 1.088 . . . . 0.0 111.819 -159.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -141.16 -147.14 0.21 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.94 1.696 . . . . 0.0 111.588 -159.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.3 m -53.07 158.26 2.51 Favored Pre-proline 0 N--CA 1.483 1.22 0 C-N-CA 126.071 1.748 . . . . 0.0 112.612 171.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.61 141.39 20.32 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.962 3.108 . . . . 0.0 113.649 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 m -142.07 140.33 32.53 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.25 1.02 . . . . 0.0 111.706 -163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.26 133.91 43.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.152 2.181 . . . . 0.0 109.365 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.98 134.26 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.591 1.156 . . . . 0.0 109.101 168.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -116.63 124.1 48.94 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.905 1.682 . . . . 0.0 109.619 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mm -108.24 142.55 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.086 1.754 . . . . 0.0 109.603 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -153.83 123.26 6.6 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.55 1.54 . . . . 0.0 110.552 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.6 t70 68.9 18.01 8.59 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.393 1.877 . . . . 0.0 114.188 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.96 23.16 39.34 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.483 1.039 . . . . 0.0 113.592 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -141.63 166.84 23.63 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.196 0.998 . . . . 0.0 112.784 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -77.99 114.52 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.65 -32.81 36.03 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 112.881 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -159.84 150.52 19.06 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.371 1.068 . . . . 0.0 112.326 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.69 133.12 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.071 1.348 . . . . 0.0 107.47 162.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -126.69 118.88 25.64 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.372 1.069 . . . . 0.0 110.198 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -110.02 131.04 55.42 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.609 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.51 -173.18 14.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.383 1.468 . . . . 0.0 114.219 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -82.71 146.72 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.56 1.144 . . . . 0.0 111.232 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.9 mmt -126.82 168.07 14.94 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.505 1.522 . . . . 0.0 113.127 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -121.73 151.45 57.39 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 128.223 2.609 . . . . 0.0 107.834 167.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.54 -36.09 15.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.983 1.789 . . . . 0.0 113.041 -161.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.69 -30.3 63.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -90.16 -23.9 21.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.271 1.029 . . . . 0.0 112.645 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -43.2 93.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.482 1.037 . . . . 0.0 110.758 166.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -57.1 -37.95 72.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.228 1.011 . . . . 0.0 111.942 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.04 69.27 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.886 0.766 . . . . 0.0 112.84 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.85 -46.71 87.09 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.768 1.167 . . . . 0.0 111.319 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -63.48 -49.68 72.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.41 66.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.74 0.816 . . . . 0.0 112.385 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -72.93 -9.82 59.12 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 126.026 1.731 . . . . 0.0 108.856 170.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -156.86 150.34 24.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.227 1.811 . . . . 0.0 110.602 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.59 18.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.016 1.326 . . . . 0.0 113.623 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.25 94.1 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.395 1.078 . . . . 0.0 111.803 -165.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.98 166.88 19.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 130.043 3.337 . . . . 0.0 108.484 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.22 138.48 54.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.966 2.107 . . . . 0.0 113.645 -173.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 pt -130.64 29.08 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.391 1.476 . . . . 0.0 113.359 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.2 m -48.43 -35.74 13.43 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 119.806 1.185 . . . . 0.0 114.107 -170.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 t -79.43 -20.49 47.37 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.229 1.412 . . . . 0.0 114.094 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -107.86 12.95 26.74 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.995 1.718 . . . . 0.0 112.515 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.35 24.11 9.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.369 1.868 . . . . 0.0 113.984 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.56 142.24 32.11 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ptp -52.41 -29.72 25.64 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.47 71.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.705 2.002 . . . . 0.0 115.752 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.14 -28.28 12.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.565 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -62.25 -25.93 68.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.722 1.146 . . . . 0.0 112.42 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -74.29 -9.45 58.62 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.256 1.423 . . . . 0.0 112.744 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.88 -0.21 9.09 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 126.667 2.08 . . . . 0.0 113.86 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.8 176.23 5.09 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.336 1.068 . . . . 0.0 111.686 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 t -120.95 -36.52 3.12 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.171 -0.955 . . . . 0.0 110.321 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -149.46 127.04 11.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.202 2.201 . . . . 0.0 109.389 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.15 146.81 15.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.154 0.982 . . . . 0.0 111.876 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 92.5 mt -133.96 132.9 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 120.607 -1.308 . . . . 0.0 109.619 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.89 119.1 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.663 0.785 . . . . 0.0 110.413 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.46 132.33 45.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.703 1.601 . . . . 0.0 110.877 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -105.56 132.14 52.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.305 1.042 . . . . 0.0 112.249 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -150.23 161.33 42.64 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -167.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -120.06 158.12 27.49 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.677 2.391 . . . . 0.0 111.321 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.79 -35.05 78.59 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.419 1.888 . . . . 0.0 113.5 166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -97.38 67.74 2.13 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.488 1.915 . . . . 0.0 109.236 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -156.21 92.48 2.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.716 0.807 . . . . 0.0 112.466 -170.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.12 -37.42 92.44 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.057 3.171 . . . . 0.0 113.031 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -67.09 -34.95 78.75 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.66 -30.32 67.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.071 1.349 . . . . 0.0 113.812 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -53.45 -46.24 69.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.122 0.969 . . . . 0.0 112.528 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -61.61 -40.14 93.75 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.659 -1.275 . . . . 0.0 110.916 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.66 -52.42 65.59 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.689 1.196 . . . . 0.0 111.74 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.38 -29.6 69.81 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.311 1.414 . . . . 0.0 112.728 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -42.27 98.6 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.547 -0.72 . . . . 0.0 111.869 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.58 -33.94 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.62 -33.71 76.58 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.256 1.022 . . . . 0.0 111.193 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.98 -50.28 74.02 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.971 0.891 . . . . 0.0 111.71 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -70.99 -22.46 62.18 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.913 0.885 . . . . 0.0 112.996 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -71.04 -51.31 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.292 1.037 . . . . 0.0 110.881 166.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.18 90.36 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 124.431 1.015 . . . . 0.0 113.249 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.03 68.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 113.516 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 -18.55 18.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.811 1.644 . . . . 0.0 113.104 174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.0 71.74 43.47 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 126.543 1.937 . . . . 0.0 111.594 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.5 -30.42 23.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.569 2.846 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -71.52 -20.04 62.1 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.05 139.4 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.953 0.901 . . . . 0.0 109.956 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.55 124.24 44.56 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.077 0.951 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -110.56 129.41 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.451 0.701 . . . . 0.0 109.156 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -128.69 162.72 26.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.786 1.634 . . . . 0.0 111.504 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.7 p -131.53 105.3 7.47 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.227 -0.92 . . . . 0.0 112.121 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.11 132.93 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 125.901 1.681 . . . . 0.0 111.811 -170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.38 89.69 1.63 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.768 1.227 . . . . 0.0 110.305 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.25 -30.81 69.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.145 0.978 . . . . 0.0 112.354 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -58.75 -28.98 66.4 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.302 1.441 . . . . 0.0 114.275 174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -97.97 1.04 47.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.074 1.35 . . . . 0.0 112.249 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.55 64.11 4.33 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.994 2.118 . . . . 0.0 111.753 176.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.19 -24.99 43.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.06 2.507 . . . . 0.0 111.916 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.76 -36.88 81.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.511 0.724 . . . . 0.0 112.191 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.7 tp -68.78 -52.51 29.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.326 0.65 . . . . 0.0 110.73 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -32.84 72.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.254 0.479 . . . . 0.0 111.79 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -65.0 -57.84 7.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.557 1.143 . . . . 0.0 111.983 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.02 -30.05 70.52 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.29 -4.96 20.11 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.454 1.502 . . . . 0.0 112.96 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.51 22.63 6.97 Favored Glycine 0 C--N 1.343 0.927 0 C-N-CA 124.809 1.195 . . . . 0.0 115.784 159.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -147.9 172.27 14.45 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.933 1.367 . . . . 0.0 113.049 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.53 38.14 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.002 0.921 . . . . 0.0 112.932 -162.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.48 -161.15 1.26 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.617 1.167 . . . . 0.0 112.783 -154.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.1 m -58.75 164.71 3.85 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 126.91 2.084 . . . . 0.0 111.925 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.77 136.99 35.09 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.863 3.042 . . . . 0.0 113.908 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -137.24 136.43 38.1 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.657 0.783 . . . . 0.0 111.771 -161.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 mt -94.33 125.05 38.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.492 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.0 t -111.88 130.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.862 1.265 . . . . 0.0 109.055 171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -113.76 130.2 56.47 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.147 1.379 . . . . 0.0 110.675 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mm -111.32 133.79 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.635 1.974 . . . . 0.0 108.529 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.6 133.96 13.49 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.912 1.285 . . . . 0.0 110.02 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.73 16.42 10.38 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.722 1.609 . . . . 0.0 113.961 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.69 23.5 55.84 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.401 1.0 . . . . 0.0 113.649 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.47 167.0 23.22 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.17 1.388 . . . . 0.0 112.216 174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.26 115.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.75 -36.88 36.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.977 1.311 . . . . 0.0 112.452 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -160.61 147.29 15.43 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.751 1.221 . . . . 0.0 112.138 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.46 121.44 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -130.01 118.8 22.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.323 1.049 . . . . 0.0 111.38 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 p -104.38 128.46 52.24 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.106 1.362 . . . . 0.0 111.056 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.14 -177.95 17.13 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.733 1.159 . . . . 0.0 113.997 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -90.14 147.03 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.879 1.271 . . . . 0.0 111.514 -173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -137.65 161.41 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.227 1.411 . . . . 0.0 112.382 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -108.2 153.62 41.77 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 127.794 2.437 . . . . 0.0 109.356 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -42.59 19.84 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.541 2.16 . . . . 0.0 112.19 -163.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -61.05 -29.96 70.04 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.678 0.791 . . . . 0.0 112.845 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -79.6 -28.87 41.02 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.673 0.789 . . . . 0.0 112.044 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -44.04 97.25 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.046 0.839 . . . . 0.0 110.261 168.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -47.4 85.68 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.625 1.17 . . . . 0.0 110.93 173.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.77 -45.43 86.4 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.24 -47.72 82.65 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.786 1.234 . . . . 0.0 111.005 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -66.01 -50.48 64.08 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.311 0.645 . . . . 0.0 112.45 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.38 -31.87 55.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.269 0.628 . . . . 0.0 111.596 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -75.45 -15.95 60.37 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 125.512 1.525 . . . . 0.0 111.383 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.746 0.308 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -170.33 160.13 7.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.457 1.103 . . . . 0.0 112.082 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.84 25.53 1.29 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.926 1.29 . . . . 0.0 112.291 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.22 95.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.051 1.34 . . . . 0.0 110.964 -162.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.95 158.51 14.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.581 2.352 . . . . 0.0 110.453 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -56.82 124.2 17.66 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.136 1.374 . . . . 0.0 112.028 176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.0 pt -129.66 34.2 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.037 1.335 . . . . 0.0 112.586 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.6 m -41.31 -36.39 0.8 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.609 1.564 . . . . 0.0 114.39 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -78.09 -23.34 48.02 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.202 1.401 . . . . 0.0 113.925 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -107.18 8.8 30.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.376 1.47 . . . . 0.0 112.402 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.35 24.5 9.93 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.828 2.051 . . . . 0.0 112.554 176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.5 147.37 34.07 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.076 1.322 . . . . 0.0 111.557 175.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 ptm -49.46 -32.56 12.23 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.08 1.352 . . . . 0.0 113.326 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.77 73.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.381 1.872 . . . . 0.0 115.57 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -104.54 -26.68 12.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.055 0.942 . . . . 0.0 112.174 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.0 m-30 -61.25 -24.46 66.39 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.08 0.952 . . . . 0.0 112.894 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.29 -8.17 55.31 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.954 1.301 . . . . 0.0 112.815 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.71 0.35 6.77 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.94 1.734 . . . . 0.0 114.188 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -71.8 179.12 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.327 1.063 . . . . 0.0 112.388 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 t -118.55 -36.93 3.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.46 1.104 . . . . 0.0 110.496 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.03 131.43 9.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.695 2.398 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.31 148.3 16.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.115 1.766 . . . . 0.0 110.531 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.2 mt -132.07 133.86 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 120.315 -1.491 . . . . 0.0 109.048 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.88 114.67 25.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.649 0.78 . . . . 0.0 109.312 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -90.68 124.11 34.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.168 1.387 . . . . 0.0 109.573 171.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -100.74 131.25 46.73 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.104 1.361 . . . . 0.0 111.135 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -146.52 159.44 43.41 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.687 1.195 . . . . 0.0 111.295 -173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -101.61 169.05 9.09 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.547 1.165 . . . . 0.0 112.892 176.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -22.93 65.96 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.736 1.615 . . . . 0.0 114.703 161.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.26 90.19 3.24 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.334 1.853 . . . . 0.0 109.023 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -154.68 132.38 6.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 125.124 1.37 . . . . 0.0 111.482 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.12 -51.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.995 3.13 . . . . 0.0 112.727 172.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -76.09 -17.12 59.76 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.56 -20.72 49.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.726 1.21 . . . . 0.0 114.088 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.47 -43.47 75.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.874 0.87 . . . . 0.0 112.558 170.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -60.83 -37.66 82.79 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.836 -1.165 . . . . 0.0 111.838 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -59.58 -39.16 83.2 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.851 0.86 . . . . 0.0 111.409 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.75 -43.51 93.12 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.306 0.957 . . . . 0.0 110.416 175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -40.41 94.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.129 0.572 . . . . 0.0 111.724 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.5 m -78.74 -34.06 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.7 mt -68.3 -29.75 68.6 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.921 0.888 . . . . 0.0 112.314 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -61.86 -52.96 62.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.692 0.797 . . . . 0.0 111.085 173.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -68.64 -34.18 75.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.617 0.767 . . . . 0.0 111.975 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.55 -48.11 70.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.304 1.041 . . . . 0.0 112.025 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.17 95.06 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 125.409 1.481 . . . . 0.0 111.752 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.49 -19.41 65.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.477 1.111 . . . . 0.0 113.962 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 -5.31 27.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.135 1.774 . . . . 0.0 112.876 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.0 61.63 41.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 126.237 1.815 . . . . 0.0 112.201 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -54.23 -29.54 57.35 Favored 'Trans proline' 0 C--N 1.35 0.623 1 C-N-CA 125.345 4.03 . . . . 0.0 115.002 -168.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -72.46 -23.82 61.1 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 p -90.05 138.23 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 121.448 0.642 . . . . 0.0 110.537 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.35 114.6 28.95 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.0 0.92 . . . . 0.0 109.927 -175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.0 mt -108.14 129.94 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.497 0.719 . . . . 0.0 110.244 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 p -126.94 163.99 22.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.736 1.614 . . . . 0.0 112.421 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -129.14 97.02 4.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 122.633 1.206 . . . . 0.0 113.573 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.26 131.0 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.667 1.587 . . . . 0.0 111.69 -172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.2 94.59 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.543 1.137 . . . . 0.0 110.318 169.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.6 p -60.81 -33.16 72.59 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.278 1.031 . . . . 0.0 112.125 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -61.4 -25.45 67.2 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.94 -1.7 57.15 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.624 1.17 . . . . 0.0 112.865 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.65 65.19 4.72 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.872 2.069 . . . . 0.0 111.753 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.53 -27.05 46.52 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.036 2.491 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.05 -33.47 73.63 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 112.348 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.6 -51.3 60.73 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.17 0.588 . . . . 0.0 109.787 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -62.26 -38.44 89.29 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.844 0.747 . . . . 0.0 111.964 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -60.52 -48.78 80.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.708 0.803 . . . . 0.0 111.826 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -71.22 -27.51 63.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -78.29 -5.24 51.47 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.639 1.576 . . . . 0.0 113.093 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 15.94 11.06 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 125.698 1.618 . . . . 0.0 116.887 162.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -154.43 163.97 39.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.855 1.828 . . . . 0.0 113.907 -173.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 25.64 0.13 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.468 1.507 . . . . 0.0 112.106 -163.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -127.13 -154.51 0.64 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.916 2.087 . . . . 0.0 112.57 -161.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.1 m -52.06 160.58 1.15 Allowed Pre-proline 0 N--CA 1.489 1.503 0 C-N-CA 126.839 2.056 . . . . 0.0 112.613 173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.45 139.12 23.32 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 124.004 3.136 . . . . 0.0 113.756 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.9 m -141.34 136.44 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.022 0.929 . . . . 0.0 111.475 -159.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.3 mt -94.6 124.31 38.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.478 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -115.99 135.85 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.826 1.25 . . . . 0.0 109.611 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.18 129.96 54.36 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.431 1.492 . . . . 0.0 110.311 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -104.94 138.02 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.186 1.795 . . . . 0.0 108.946 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -146.3 131.95 18.87 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.951 1.7 . . . . 0.0 109.971 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 66.02 18.35 11.01 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.874 1.27 . . . . 0.0 114.134 168.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.75 19.62 50.78 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.145 1.355 . . . . 0.0 113.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 169.18 18.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.431 1.115 . . . . 0.0 113.12 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.3 t -76.77 115.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.249 -0.907 . . . . 0.0 109.289 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.67 -40.81 55.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.272 1.429 . . . . 0.0 112.898 175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -161.08 149.09 15.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.983 0.913 . . . . 0.0 112.864 -167.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.09 123.41 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.897 1.679 . . . . 0.0 107.84 168.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -128.25 113.06 15.18 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.532 1.533 . . . . 0.0 110.302 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.4 p -94.75 122.6 37.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 110.726 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.06 -164.66 24.46 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.187 0.899 . . . . 0.0 113.616 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.32 141.84 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.197 1.399 . . . . 0.0 111.125 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.1 mmt -119.96 165.45 14.64 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.587 1.555 . . . . 0.0 113.534 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.409 HD21 ' HG2' ' A' ' 96' ' ' GLU . 4.3 p-10 -121.05 152.35 56.52 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 127.482 2.313 . . . . 0.0 108.754 165.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.19 -35.96 10.47 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.085 1.856 . . . . 0.0 112.995 -161.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -56.61 -35.12 67.91 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.471 1.108 . . . . 0.0 112.817 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 93' ' ' ASN . 34.6 mm-40 -81.45 -27.17 34.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.844 0.858 . . . . 0.0 112.003 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -43.81 95.42 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.991 0.814 . . . . 0.0 111.2 171.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.6 -47.05 80.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.457 1.103 . . . . 0.0 111.425 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.28 88.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.66 -47.15 82.43 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.831 0.852 . . . . 0.0 110.815 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -64.42 -45.7 86.45 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.45 -0.781 . . . . 0.0 112.872 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.78 66.41 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.02 0.928 . . . . 0.0 112.72 173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 t -72.32 -39.91 67.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.51 -0.744 . . . . 0.0 110.685 171.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.777 0.831 . . . . 0.0 109.836 179.274 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.7 p -160.99 178.55 9.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.28 1.032 . . . . 0.0 112.217 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.31 10.52 27.64 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.414 1.485 . . . . 0.0 113.43 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.56 103.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.446 1.898 . . . . 0.0 112.007 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.83 41.85 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 128.842 2.857 . . . . 0.0 108.858 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.48 139.97 58.55 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.795 1.638 . . . . 0.0 111.439 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.0 pt -126.81 24.58 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.0 m -45.57 -37.72 5.77 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -170.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -78.36 -18.54 54.97 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.826 1.251 . . . . 0.0 113.932 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -113.43 10.2 18.24 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.828 1.651 . . . . 0.0 112.951 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.74 1.18 26.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.99 143.48 39.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.469 1.033 . . . . 0.0 112.056 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.5 ptm -51.02 -32.39 21.32 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.262 1.025 . . . . 0.0 113.736 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.54 -53.21 31.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.305 1.842 . . . . 0.0 113.706 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.17 -27.21 18.66 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.258 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -59.9 -28.23 67.41 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 120.316 1.416 . . . . 0.0 113.132 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -78.8 -3.29 43.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.205 1.002 . . . . 0.0 112.839 171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.8 -2.06 11.56 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.418 1.961 . . . . 0.0 113.994 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.1 mt -71.45 -177.13 1.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 118.404 1.102 . . . . 0.0 112.723 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 t -125.24 -35.29 2.63 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.018 1.327 . . . . 0.0 110.05 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -151.99 152.55 32.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.831 2.452 . . . . 0.0 108.774 171.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -172.71 136.72 0.74 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.742 1.617 . . . . 0.0 111.169 164.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.22 129.87 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.069 -1.019 . . . . 0.0 108.548 171.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 t -131.09 122.01 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.673 0.789 . . . . 0.0 110.247 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.01 123.13 45.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.139 1.376 . . . . 0.0 110.012 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -101.95 134.71 44.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.479 1.512 . . . . 0.0 111.53 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -151.98 162.19 41.46 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -171.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -136.87 149.45 47.68 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.891 2.076 . . . . 0.0 109.364 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -20.6 2.67 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.172 1.789 . . . . 0.0 114.846 176.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.96 5.09 43.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.996 1.718 . . . . 0.0 114.755 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 29.3 p -94.34 116.25 66.19 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.015 0.926 . . . . 0.0 110.507 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.89 -43.14 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.613 2.875 . . . . 0.0 112.185 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -73.06 -23.66 60.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.0 p -66.63 -10.21 43.58 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -56.11 -40.41 73.68 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.756 -1.215 . . . . 0.0 112.404 164.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -63.0 -37.19 86.18 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.185 -0.947 . . . . 0.0 111.468 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -45.04 42.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.505 1.522 . . . . 0.0 112.124 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.39 -43.97 89.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.321 0.964 . . . . 0.0 110.854 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -43.55 90.63 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.256 0.622 . . . . 0.0 111.185 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.47 -32.93 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.6 mt -68.68 -31.74 71.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.026 0.931 . . . . 0.0 112.457 172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.03 -50.67 46.6 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.98 0.809 . . . . 0.0 111.401 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.83 -27.48 68.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.928 0.891 . . . . 0.0 112.672 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -74.26 -49.68 22.18 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.813 1.245 . . . . 0.0 111.723 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.87 -31.07 63.98 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.875 1.226 . . . . 0.0 112.877 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 -31.39 68.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.066 1.346 . . . . 0.0 113.197 173.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -11.37 18.73 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.221 1.409 . . . . 0.0 113.359 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.87 55.88 7.93 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.063 1.345 . . . . 0.0 113.237 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.56 -27.81 85.5 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.566 3.511 . . . . 0.0 113.818 -166.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -73.81 -19.66 60.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.02 145.9 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.849 0.859 . . . . 0.0 110.355 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.46 109.43 21.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.381 0.672 . . . . 0.0 110.138 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.45 132.37 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.333 0.653 . . . . 0.0 110.053 171.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 m -129.57 155.97 44.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 111.287 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 p -123.73 108.84 12.97 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 120.587 -1.32 . . . . 0.0 113.319 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.8 t -105.6 131.3 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.474 1.509 . . . . 0.0 112.246 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -72.45 91.42 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.799 1.24 . . . . 0.0 110.749 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -60.79 -32.59 71.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.254 1.022 . . . . 0.0 112.724 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -60.23 -26.61 66.55 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.562 1.145 . . . . 0.0 113.778 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.14 2.3 40.05 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.019 1.328 . . . . 0.0 112.183 -177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.62 61.5 5.68 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 127.286 2.234 . . . . 0.0 111.577 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.61 -25.92 28.82 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.416 2.744 . . . . 0.0 113.234 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.02 -39.06 83.21 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.693 0.678 . . . . 0.0 112.082 173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.62 -55.32 18.23 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.775 0.83 . . . . 0.0 109.434 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.75 79.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -59.57 -53.94 52.31 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.09 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -69.01 -22.76 64.05 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 tp -76.17 -6.8 52.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.014 1.325 . . . . 0.0 112.826 172.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.79 3.58 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 160.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.06 164.23 28.25 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.073 1.349 . . . . 0.0 110.921 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.91 28.35 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.03 1.332 . . . . 0.0 111.995 -160.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -134.87 -154.6 0.59 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.823 2.049 . . . . 0.0 111.937 -159.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 33.0 m -54.2 153.57 9.31 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 124.715 1.206 . . . . 0.0 112.022 171.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -54.35 143.11 67.09 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.148 3.232 . . . . 0.0 113.659 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.3 m -138.08 140.41 39.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.985 0.914 . . . . 0.0 112.928 -153.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.0 mt -97.17 127.92 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.751 2.02 . . . . 0.0 109.305 170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.1 133.05 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.729 1.612 . . . . 0.0 109.472 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -120.22 120.84 37.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.912 1.685 . . . . 0.0 110.804 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.99 141.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.332 1.853 . . . . 0.0 109.903 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -150.31 121.85 7.98 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.349 1.86 . . . . 0.0 109.22 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 65.33 16.72 10.68 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.897 1.679 . . . . 0.0 114.867 169.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.46 21.52 44.04 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.336 0.97 . . . . 0.0 113.699 -174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 163.41 30.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.533 1.133 . . . . 0.0 112.409 168.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.0 p -81.03 117.53 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.401 0.619 . . . . 0.0 109.594 172.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.69 -36.37 37.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.458 1.103 . . . . 0.0 112.661 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -160.35 145.85 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.413 1.085 . . . . 0.0 112.813 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -125.74 127.0 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.386 1.474 . . . . 0.0 107.316 162.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -135.62 116.51 14.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.618 1.167 . . . . 0.0 111.034 -176.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.9 p -98.53 119.82 37.9 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.998 0.919 . . . . 0.0 111.36 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.82 -175.98 16.15 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 124.333 0.968 . . . . 0.0 114.366 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.9 mm -86.69 146.24 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.14 1.376 . . . . 0.0 111.878 -168.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.6 ptp -150.44 174.28 13.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 168.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.57 164.02 17.4 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 125.288 1.435 . . . . 0.0 112.004 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -63.74 -38.69 38.39 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.209 2.606 . . . . 0.0 113.227 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -57.22 -34.81 68.92 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.971 1.309 . . . . 0.0 112.502 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.22 -34.16 56.07 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.121 0.968 . . . . 0.0 111.367 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -44.63 96.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.044 170.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.54 -47.12 85.24 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.157 1.383 . . . . 0.0 111.364 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.45 82.54 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -60.07 -46.49 89.39 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.261 1.024 . . . . 0.0 111.067 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -61.72 -51.15 69.57 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.327 0.651 . . . . 0.0 112.624 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.3 -32.35 64.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.411 0.684 . . . . 0.0 111.728 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.0 m -73.27 -20.95 60.72 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 125.351 1.46 . . . . 0.0 111.703 178.28 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -82.69 142.96 31.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.393 1.077 . . . . 0.0 111.676 172.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.46 16.8 12.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 112.031 166.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 55.6 mt -74.42 85.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.268 1.027 . . . . 0.0 111.22 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -128.4 148.33 50.7 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 127.916 2.486 . . . . 0.0 109.892 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.49 110.83 4.36 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.702 2.001 . . . . 0.0 111.233 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.95 32.82 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -166.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.7 m -46.43 -34.16 4.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.172 -1.58 . . . . 0.0 114.343 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -73.61 -20.63 60.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.357 1.063 . . . . 0.0 113.631 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.2 6.4 20.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.119 1.768 . . . . 0.0 112.571 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.85 21.01 11.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.018 1.727 . . . . 0.0 113.964 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.39 143.33 34.06 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.715 1.15 . . . . 0.0 111.439 170.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.9 ptm -50.72 -32.42 19.49 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.444 1.098 . . . . 0.0 113.415 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.64 -52.68 45.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.006 1.722 . . . . 0.0 113.995 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -90.83 -28.48 18.15 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.812 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -58.08 -30.81 66.52 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 120.509 1.504 . . . . 0.0 112.93 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.98 -4.58 44.77 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.391 1.076 . . . . 0.0 112.904 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.03 -0.64 13.12 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.178 1.847 . . . . 0.0 113.758 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.38 173.85 9.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.629 1.214 . . . . 0.0 111.448 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -113.74 -39.78 3.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 109.908 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -155.14 127.6 7.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.138 2.175 . . . . 0.0 109.191 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.42 145.7 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.162 0.985 . . . . 0.0 112.009 174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.3 mt -126.92 135.77 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.978 -1.076 . . . . 0.0 109.099 168.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.3 124.22 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 123.736 0.815 . . . . 0.0 110.099 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -94.32 138.89 31.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.463 1.505 . . . . 0.0 110.473 172.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -105.64 131.05 53.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.854 1.262 . . . . 0.0 111.14 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -153.46 167.18 30.3 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -115.25 163.67 15.33 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.264 1.426 . . . . 0.0 112.864 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.94 -28.88 64.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.723 2.009 . . . . 0.0 114.204 164.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.4 mt -128.14 80.56 1.97 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.307 1.443 . . . . 0.0 110.05 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -157.77 115.71 1.86 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.759 1.224 . . . . 0.0 111.466 167.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.81 -31.92 6.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.58 2.187 . . . . 0.0 111.991 175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -61.87 -34.65 76.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.733 0.813 . . . . 0.0 112.141 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 86.6 m -56.44 -37.14 69.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.175 1.39 . . . . 0.0 113.241 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -57.47 -40.11 77.85 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -55.22 -42.09 72.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.831 1.253 . . . . 0.0 111.504 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -59.37 -44.4 92.72 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.036 0.535 . . . . 0.0 111.431 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -64.27 -39.47 94.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.871 0.868 . . . . 0.0 110.715 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -36.17 83.24 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -87.46 -31.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -64.2 -29.67 70.77 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.877 1.271 . . . . 0.0 112.103 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.23 -55.65 31.22 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.191 0.905 . . . . 0.0 111.681 170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.97 -31.39 72.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.81 0.844 . . . . 0.0 112.555 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.81 -47.38 66.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.744 0.817 . . . . 0.0 111.811 171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.41 96.2 Favored Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.829 1.204 . . . . 0.0 112.753 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.75 -25.17 64.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 170.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -8.49 22.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.782 1.633 . . . . 0.0 113.407 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.59 58.78 18.18 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.088 1.355 . . . . 0.0 113.04 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.62 -27.18 84.38 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 124.915 3.743 . . . . 0.0 114.471 -165.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -71.03 -20.33 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.44 153.42 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.154 1.381 . . . . 0.0 110.551 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.96 134.31 55.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.296 1.038 . . . . 0.0 109.703 170.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.0 122.62 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.741 0.816 . . . . 0.0 108.947 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.3 m -122.86 179.93 4.47 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.797 1.239 . . . . 0.0 110.363 173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -118.78 177.07 4.98 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 119.737 -1.852 . . . . 0.0 113.878 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.2 t -147.35 129.6 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.847 2.459 . . . . 0.0 110.236 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -72.11 91.17 1.24 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.224 1.409 . . . . 0.0 110.842 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 p -60.48 -31.47 70.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.229 1.011 . . . . 0.0 113.223 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.74 -28.64 67.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.08 1.14 39.06 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.905 0.882 . . . . 0.0 112.187 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 61.05 3.95 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 126.924 2.09 . . . . 0.0 111.307 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.83 -26.01 32.59 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.284 2.656 . . . . 0.0 112.613 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.79 -36.63 78.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.942 0.897 . . . . 0.0 112.178 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.1 tp -64.07 -51.99 61.44 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.386 0.674 . . . . 0.0 109.673 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.1 ttp -48.65 -49.55 36.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.074 1.35 . . . . 0.0 112.098 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.64 -50.04 74.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.927 0.891 . . . . 0.0 112.431 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -70.02 -24.73 63.33 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.6 tp -80.99 -4.37 54.87 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.424 1.49 . . . . 0.0 112.061 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.56 14.62 9.44 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 116.504 1.362 . . . . 0.0 116.504 160.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.05 167.09 27.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.594 1.697 . . . . 0.0 113.763 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.97 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.841 1.656 . . . . 0.0 111.197 -170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -157.01 -154.38 0.46 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.914 1.286 . . . . 0.0 112.072 -157.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.5 m -49.13 155.94 1.06 Allowed Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.049 1.74 . . . . 0.0 112.204 170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -54.31 144.51 60.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.927 3.085 . . . . 0.0 112.865 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.7 m -142.67 136.98 29.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.202 0.601 . . . . 0.0 111.939 -157.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 mt -87.99 139.35 30.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.829 1.652 . . . . 0.0 109.759 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.5 t -129.8 133.35 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.325 1.05 . . . . 0.0 110.365 168.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -116.23 130.37 56.75 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.333 1.853 . . . . 0.0 111.209 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -111.11 135.63 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 127.028 2.131 . . . . 0.0 108.788 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -147.4 129.18 15.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.161 1.785 . . . . 0.0 108.773 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.7 t70 68.79 18.4 8.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.659 1.584 . . . . 0.0 114.094 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.12 24.4 48.39 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.476 1.036 . . . . 0.0 113.324 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.72 163.25 35.52 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.688 1.195 . . . . 0.0 112.868 173.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.0 t -77.95 115.64 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.02 -36.08 31.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.013 0.925 . . . . 0.0 113.245 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -155.66 146.2 21.98 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -125.64 128.25 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.322 1.849 . . . . 0.0 106.908 163.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -133.59 110.28 9.8 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 110.622 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -97.82 126.79 43.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.256 1.422 . . . . 0.0 111.541 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.74 -168.95 21.01 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.963 1.268 . . . . 0.0 113.604 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.22 149.02 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.52 1.528 . . . . 0.0 110.735 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -153.98 167.73 28.79 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.351 1.06 . . . . 0.0 113.787 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.85 164.97 15.11 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 126.176 1.79 . . . . 0.0 110.903 172.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.96 -35.37 43.86 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.64 2.226 . . . . 0.0 113.484 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -58.07 -36.88 73.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.357 1.063 . . . . 0.0 111.941 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.85 -26.94 49.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.916 0.886 . . . . 0.0 111.673 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -44.95 83.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.166 0.894 . . . . 0.0 111.164 170.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -55.37 -45.11 76.56 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.078 0.951 . . . . 0.0 111.261 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.79 88.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.241 0.617 . . . . 0.0 112.602 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.8 -42.2 97.12 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.617 1.167 . . . . 0.0 111.691 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -68.59 -47.19 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.41 -25.1 64.02 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.763 -0.586 . . . . 0.0 112.485 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 m -72.18 -20.61 61.56 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.088 1.355 . . . . 0.0 109.868 171.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 p -77.22 148.71 35.68 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.478 1.111 . . . . 0.0 113.097 174.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.31 22.73 1.34 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.856 1.262 . . . . 0.0 112.655 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 59.5 mt -72.38 91.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.952 1.301 . . . . 0.0 110.89 -164.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.33 157.99 36.66 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 128.47 2.708 . . . . 0.0 108.925 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -60.29 127.24 30.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.964 1.306 . . . . 0.0 110.643 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -130.19 41.37 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.464 1.106 . . . . 0.0 112.263 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 98.8 m -47.0 -30.55 2.67 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 t -75.41 -22.56 57.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.659 1.584 . . . . 0.0 113.815 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -110.59 -1.19 16.97 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.899 1.68 . . . . 0.0 113.465 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -115.02 20.92 14.7 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.196 1.798 . . . . 0.0 114.193 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.91 148.24 39.43 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.776 1.179 . . . . 0.0 111.805 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.6 ptm -51.65 -32.55 29.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.217 1.007 . . . . 0.0 113.505 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.04 -50.5 68.92 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.786 1.635 . . . . 0.0 113.481 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -26.58 19.65 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.243 175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 2.3 m-30 -60.56 -27.12 67.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.928 1.24 . . . . 0.0 113.477 173.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.58 -7.68 52.87 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.112 1.365 . . . . 0.0 112.775 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.26 -0.95 8.72 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.169 1.843 . . . . 0.0 113.952 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.97 178.64 4.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.56 1.18 . . . . 0.0 111.988 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -120.22 -39.7 2.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.254 1.021 . . . . 0.0 110.045 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -149.39 130.39 14.38 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.094 2.158 . . . . 0.0 110.115 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.55 152.96 20.62 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.655 1.182 . . . . 0.0 111.834 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 94.1 mt -136.86 137.36 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.316 -1.49 . . . . 0.0 107.934 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -135.73 123.64 36.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 123.074 0.55 . . . . 0.0 109.654 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -98.42 120.91 39.66 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.153 1.381 . . . . 0.0 109.183 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.69 137.35 37.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.004 1.722 . . . . 0.0 110.248 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -153.71 158.97 41.81 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -114.07 163.73 14.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.166 1.787 . . . . 0.0 112.358 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.07 -29.93 33.1 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.691 1.997 . . . . 0.0 113.942 164.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.7 mt -83.74 45.49 1.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.206 1.802 . . . . 0.0 112.223 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.0 t -111.89 110.24 54.56 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.768 1.627 . . . . 0.0 112.804 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -92.99 -40.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.734 2.956 . . . . 0.0 112.245 155.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -91.36 -31.11 16.18 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 p -60.04 -19.16 51.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.774 1.17 . . . . 0.0 113.936 -175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -51.3 -43.72 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 0.0 112.668 167.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -63.72 -34.81 78.71 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.767 -1.208 . . . . 0.0 111.483 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.0 ttm -60.51 -48.5 81.51 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.536 1.534 . . . . 0.0 111.395 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -69.65 -30.41 68.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.553 1.07 . . . . 0.0 112.99 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -42.15 99.65 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.254 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.44 -34.47 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 69.2 mt -60.43 -33.96 73.28 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.718 0.69 . . . . 0.0 112.816 168.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.89 -51.82 62.78 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.124 0.875 . . . . 0.0 111.383 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -61.42 -31.47 71.4 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.847 0.859 . . . . 0.0 112.791 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -67.71 -51.11 53.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.587 1.155 . . . . 0.0 111.606 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.75 -35.18 91.57 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.329 0.966 . . . . 0.0 112.896 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.03 -27.34 68.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.634 1.174 . . . . 0.0 113.852 171.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -15.54 18.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 113.362 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.15 71.47 22.7 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.751 1.62 . . . . 0.0 111.367 -177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.69 -31.25 49.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.225 3.283 . . . . 0.0 113.551 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -72.95 -19.97 61.14 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.05 143.85 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.956 0.902 . . . . 0.0 110.315 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.97 136.89 44.82 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.157 0.983 . . . . 0.0 110.066 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.88 136.37 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.338 1.055 . . . . 0.0 109.856 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.4 p -130.7 161.09 32.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.391 1.876 . . . . 0.0 111.574 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.9 p -124.35 90.32 3.24 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.449 1.118 . . . . 0.0 113.414 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 79.2 t -88.3 132.51 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.75 1.62 . . . . 0.0 111.933 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -73.33 91.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.696 1.199 . . . . 0.0 110.516 172.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 p -60.94 -31.61 71.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.002 0.921 . . . . 0.0 112.753 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.5 -23.22 67.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.48 -0.03 49.63 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.291 1.036 . . . . 0.0 112.056 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.51 61.12 6.64 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 127.263 2.225 . . . . 0.0 110.956 172.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.95 -24.24 29.04 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.982 2.455 . . . . 0.0 112.934 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.36 -37.73 87.92 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.824 0.85 . . . . 0.0 112.176 172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.97 -50.03 52.64 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.162 0.585 . . . . 0.0 110.01 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 54.9 ttp -49.47 -47.22 48.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.502 1.121 . . . . 0.0 111.749 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -65.12 -50.96 64.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.734 1.213 . . . . 0.0 111.96 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -29.54 69.06 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.79 -9.33 19.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.65 1.18 . . . . 0.0 112.874 168.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.51 25.78 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.784 1.183 . . . . 0.0 114.279 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -142.7 163.78 31.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.676 1.238 . . . . 0.0 113.541 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.53 24.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.839 1.255 . . . . 0.0 112.91 -160.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -127.2 -153.34 0.56 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.957 2.103 . . . . 0.0 113.105 -161.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.5 m -54.9 162.04 2.05 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 126.238 1.815 . . . . 0.0 112.34 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -47.11 147.12 5.59 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.831 3.687 . . . . 0.0 113.765 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -152.83 135.32 15.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.097 0.559 . . . . 0.0 112.487 -156.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.0 mt -80.5 137.56 36.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.504 1.922 . . . . 0.0 110.905 166.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.69 134.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.086 1.755 . . . . 0.0 109.469 167.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.62 126.51 52.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.828 1.651 . . . . 0.0 111.156 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 mm -107.2 128.25 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.231 1.812 . . . . 0.0 109.405 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -142.25 132.38 24.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.362 1.465 . . . . 0.0 109.105 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 t0 69.93 18.67 7.2 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.635 1.574 . . . . 0.0 113.945 171.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.23 21.72 50.98 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.918 1.247 . . . . 0.0 113.73 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.83 162.63 39.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.254 1.027 . . . . 0.0 112.811 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.68 117.63 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.52 -29.54 17.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.707 1.203 . . . . 0.0 113.814 175.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -155.55 149.6 25.6 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.44 131.73 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.468 1.907 . . . . 0.0 107.821 165.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -139.62 113.8 8.94 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.114 0.966 . . . . 0.0 111.893 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -97.15 88.85 4.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.677 1.191 . . . . 0.0 111.974 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.59 28.33 Favored Glycine 0 C--N 1.348 1.199 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.4 mm -84.63 147.87 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.835 1.654 . . . . 0.0 109.683 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -153.87 -177.56 6.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.17 1.388 . . . . 0.0 111.38 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.22 159.54 31.84 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.547 1.139 . . . . 0.0 111.105 171.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.8 -33.44 53.53 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.055 2.503 . . . . 0.0 113.796 -172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -57.57 -36.21 71.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.995 0.918 . . . . 0.0 112.252 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.76 -31.4 57.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.914 0.886 . . . . 0.0 111.417 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -45.35 93.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.175 0.59 . . . . 0.0 110.794 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.35 -47.27 82.03 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.037 1.335 . . . . 0.0 111.815 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.6 -46.21 83.63 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.27 -44.71 96.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.421 1.088 . . . . 0.0 110.88 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -62.58 -53.13 59.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.585 0.754 . . . . 0.0 112.914 176.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.99 62.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.773 0.829 . . . . 0.0 112.445 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.1 t -74.59 -17.54 60.7 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 94.8 mt . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.185 1.394 . . . . 0.0 110.893 178.617 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.9 p -83.55 -176.28 6.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.829 1.252 . . . . 0.0 113.308 174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.26 8.99 38.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.56 1.544 . . . . 0.0 112.829 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.3 mt -65.33 94.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.381 1.472 . . . . 0.0 111.45 -168.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.72 161.53 42.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 129.836 3.254 . . . . 0.0 107.781 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -63.39 130.67 45.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.701 1.6 . . . . 0.0 111.412 169.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 pt -126.62 27.4 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.228 1.411 . . . . 0.0 113.107 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.3 m -44.24 -36.29 2.65 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -75.52 -22.99 56.65 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.695 1.198 . . . . 0.0 113.19 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -107.32 10.7 29.65 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.237 1.815 . . . . 0.0 112.574 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -121.02 21.45 11.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.919 1.687 . . . . 0.0 113.667 -176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 143.81 35.55 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.188 0.899 . . . . 0.0 110.864 172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.0 ptp -51.65 -31.11 24.18 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.281 1.032 . . . . 0.0 113.476 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.76 -52.11 51.24 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.979 1.712 . . . . 0.0 114.179 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -92.59 -27.61 17.24 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 117.941 -1.028 . . . . 0.0 112.059 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.415 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.3 m-30 -58.21 -30.97 66.89 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.285 1.402 . . . . 0.0 113.314 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -79.1 -0.72 32.72 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.63 1.172 . . . . 0.0 112.496 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.56 1.53 8.74 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.726 2.108 . . . . 0.0 113.829 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.38 -172.77 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.936 1.368 . . . . 0.0 112.306 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 t -128.63 -34.92 1.96 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.342 1.457 . . . . 0.0 110.331 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -152.57 150.27 29.37 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.116 2.566 . . . . 0.0 108.967 172.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -171.52 139.99 1.32 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.307 1.843 . . . . 0.0 110.677 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.3 mt -122.63 131.62 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.411 -1.431 . . . . 0.0 108.466 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.62 114.68 23.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 123.774 0.83 . . . . 0.0 109.864 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -96.53 127.3 42.39 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.666 1.187 . . . . 0.0 110.021 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -100.54 131.26 46.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.113 1.365 . . . . 0.0 110.961 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.11 160.12 43.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.32 1.048 . . . . 0.0 112.866 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -113.8 147.94 37.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.943 2.097 . . . . 0.0 108.777 169.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -36.03 70.96 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.863 1.665 . . . . 0.0 113.858 176.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.3 mt -97.97 76.83 2.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.163 2.185 . . . . 0.0 108.834 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -154.59 105.28 2.35 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.226 1.411 . . . . 0.0 110.949 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.99 -42.94 21.4 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.207 3.271 . . . . 0.0 113.365 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -69.33 -31.2 69.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.3 m -58.49 -30.19 66.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 113.597 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -54.35 -46.37 72.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.263 1.425 . . . . 0.0 111.418 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -58.99 -36.92 75.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.425 1.49 . . . . 0.0 111.944 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -64.5 -51.2 64.17 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.912 0.885 . . . . 0.0 111.106 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -56.86 -39.07 73.64 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.864 1.211 . . . . 0.0 111.264 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -16.07 63.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.546 1.539 . . . . 0.0 113.77 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.51 -31.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.593 1.157 . . . . 0.0 114.114 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.2 mt -67.21 -33.0 74.43 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.415 1.486 . . . . 0.0 111.904 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.01 -48.24 66.28 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 122.142 0.972 . . . . 0.0 110.792 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.22 -35.74 79.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.006 1.322 . . . . 0.0 111.588 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -68.3 -49.33 61.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.468 1.507 . . . . 0.0 111.177 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.46 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.568 1.08 . . . . 0.0 113.016 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.07 -27.46 66.99 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.337 1.055 . . . . 0.0 113.546 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.6 -4.27 22.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.447 1.899 . . . . 0.0 113.481 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.24 61.34 52.64 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.947 1.699 . . . . 0.0 112.837 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -54.95 -30.22 68.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 125.08 3.854 . . . . 0.0 114.755 -169.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -22.9 62.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.32 149.12 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.638 1.175 . . . . 0.0 111.278 -176.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.66 125.43 54.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.621 0.768 . . . . 0.0 110.412 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.6 134.18 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.939 0.896 . . . . 0.0 110.454 175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.5 p -123.9 164.97 18.19 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.347 1.859 . . . . 0.0 111.783 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 p -129.55 100.92 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.14 0.971 . . . . 0.0 112.625 177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.37 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.538 1.535 . . . . 0.0 112.247 -173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -70.46 90.82 0.74 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.25 1.42 . . . . 0.0 111.176 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -62.62 -30.8 71.62 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.665 1.186 . . . . 0.0 112.501 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.53 -26.19 63.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.571 1.548 . . . . 0.0 113.796 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.92 1.73 31.65 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.018 1.327 . . . . 0.0 112.098 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 61.94 5.7 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 126.613 1.965 . . . . 0.0 111.831 170.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.96 -28.13 29.55 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.678 2.919 . . . . 0.0 112.988 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.32 -38.87 81.98 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.679 0.672 . . . . 0.0 111.682 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.48 -53.73 38.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.456 0.703 . . . . 0.0 110.599 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -32.78 74.34 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.271 0.487 . . . . 0.0 111.809 -177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -60.52 -56.62 19.18 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.259 1.024 . . . . 0.0 112.038 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.6 -22.3 66.66 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.08 -4.92 46.78 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.743 1.617 . . . . 0.0 112.973 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.96 16.81 8.85 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 116.213 1.245 . . . . 0.0 116.213 162.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.35 165.34 33.36 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.333 1.566 . . . . 0.0 114.104 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.09 38.12 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.003 1.321 . . . . 0.0 111.815 -166.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -146.52 -150.61 0.34 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.776 1.231 . . . . 0.0 112.558 -159.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.16 157.34 3.14 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 125.577 1.551 . . . . 0.0 112.304 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -51.63 140.94 44.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.164 3.243 . . . . 0.0 113.006 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.4 m -136.29 137.17 40.43 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.439 0.695 . . . . 0.0 112.329 -161.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.7 mt -92.55 136.31 33.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.227 1.811 . . . . 0.0 109.338 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.55 134.28 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.326 1.45 . . . . 0.0 109.734 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -120.47 121.66 38.98 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.524 1.53 . . . . 0.0 110.566 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.65 138.53 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.243 1.817 . . . . 0.0 108.62 173.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.97 129.13 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.874 1.67 . . . . 0.0 109.979 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 67.95 17.14 9.61 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.805 2.042 . . . . 0.0 114.278 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.97 24.02 53.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.608 0.623 . . . . 0.0 112.979 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.75 164.17 30.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.686 1.195 . . . . 0.0 111.807 168.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 118.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.75 -31.1 17.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 112.724 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -155.92 147.09 22.44 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -123.98 135.4 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.46 1.904 . . . . 0.0 107.084 161.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -144.35 110.79 5.57 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.667 1.187 . . . . 0.0 109.671 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -99.27 121.08 40.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.976 1.311 . . . . 0.0 110.563 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.15 -172.22 20.77 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.755 1.169 . . . . 0.0 114.714 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 mm -91.85 147.54 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.262 1.425 . . . . 0.0 111.264 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.5 mtp -140.21 156.35 46.54 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.943 1.297 . . . . 0.0 112.23 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -99.68 155.64 36.26 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.733 2.413 . . . . 0.0 109.494 167.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.09 -40.53 15.5 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.232 1.955 . . . . 0.0 112.739 -165.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -61.7 -30.66 70.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.523 0.729 . . . . 0.0 112.735 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.11 -28.79 54.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.62 0.768 . . . . 0.0 112.337 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -44.38 94.32 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.773 0.829 . . . . 0.0 110.565 169.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -48.13 79.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.478 1.111 . . . . 0.0 110.758 172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.87 96.11 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.548 0.739 . . . . 0.0 112.951 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.41 -42.11 88.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.447 1.099 . . . . 0.0 111.308 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -62.69 -48.52 78.93 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.757 -0.589 . . . . 0.0 112.497 172.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.4 -24.72 65.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.157 0.583 . . . . 0.0 112.458 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.9 m -79.21 -10.32 59.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.351 1.06 . . . . 0.0 113.543 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.653 1.581 . . . . 0.0 111.468 177.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -84.67 -175.35 5.74 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.42 18.62 15.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.245 1.818 . . . . 0.0 112.409 -168.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 42.3 mt -67.15 98.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.817 1.647 . . . . 0.0 111.776 -163.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.22 161.84 12.5 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.047 2.139 . . . . 0.0 111.823 168.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -42.35 120.87 1.75 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.034 2.534 . . . . 0.0 114.673 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.6 pt -122.14 30.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 171.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 m -43.29 -35.92 1.65 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -74.49 -21.38 59.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.091 1.356 . . . . 0.0 113.434 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -110.54 6.75 22.19 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.973 1.709 . . . . 0.0 112.713 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.52 21.04 11.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.841 1.656 . . . . 0.0 114.216 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.17 141.17 33.74 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 167.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -51.71 -31.47 26.35 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 0.0 113.694 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.87 -51.01 62.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.532 1.933 . . . . 0.0 113.952 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -94.62 -24.92 16.99 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.104 -0.951 . . . . 0.0 112.174 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.92 -32.33 63.69 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 120.228 1.376 . . . . 0.0 112.787 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.19 -2.74 36.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.177 0.991 . . . . 0.0 113.199 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.05 -1.2 12.96 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.27 1.89 . . . . 0.0 113.728 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.68 175.48 7.12 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.715 1.257 . . . . 0.0 112.38 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.2 m -112.89 -32.15 6.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.028 1.331 . . . . 0.0 110.83 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -172.22 123.32 0.49 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 0.0 109.364 -171.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.33 131.55 8.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.402 1.081 . . . . 0.0 111.387 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.5 mt -110.91 132.52 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.304 168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.85 126.21 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 122.057 0.932 . . . . 0.0 111.643 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -100.68 115.41 30.17 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.849 2.059 . . . . 0.0 111.136 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -89.71 129.27 36.15 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.406 1.482 . . . . 0.0 110.099 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -155.49 165.2 37.33 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.904 0.881 . . . . 0.0 112.913 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -127.32 154.64 44.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.93 2.492 . . . . 0.0 109.784 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -22.48 45.85 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 mt -106.01 7.25 31.85 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.492 1.517 . . . . 0.0 114.84 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.7 p -87.5 122.84 70.41 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.016 -1.052 . . . . 0.0 111.192 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.14 -43.02 0.1 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.207 3.272 . . . . 0.0 112.666 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -71.63 -26.86 62.74 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.121 -0.987 . . . . 0.0 112.828 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -64.47 -16.84 63.17 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.85 1.26 . . . . 0.0 113.398 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.52 -41.26 69.46 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.209 -0.932 . . . . 0.0 112.242 170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -65.45 -35.08 79.86 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.143 -0.973 . . . . 0.0 111.843 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -54.81 -40.9 70.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.058 0.943 . . . . 0.0 111.838 173.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.89 -43.7 95.2 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.75 1.159 . . . . 0.0 110.666 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -40.45 95.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.425 0.69 . . . . 0.0 111.839 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.11 -33.49 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.7 mt -65.79 -32.06 73.38 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.195 0.998 . . . . 0.0 111.831 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.33 -49.6 74.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.036 0.922 . . . . 0.0 111.052 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -71.44 -24.0 61.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.763 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -67.97 -51.95 41.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 166.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.8 -39.17 95.02 Favored Glycine 0 N--CA 1.472 1.065 0 C-N-CA 124.451 1.024 . . . . 0.0 112.563 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.49 -28.45 69.31 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.964 1.306 . . . . 0.0 113.891 173.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -8.52 25.95 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.122 1.769 . . . . 0.0 113.087 176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.66 62.89 50.85 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 125.814 1.646 . . . . 0.0 112.377 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 -30.41 77.49 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 125.226 3.951 . . . . 0.0 114.428 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -70.67 -20.9 62.66 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.18 133.56 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.661 1.184 . . . . 0.0 108.958 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.65 120.94 39.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.567 0.747 . . . . 0.0 109.107 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.45 127.53 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 123.149 0.58 . . . . 0.0 110.303 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.4 m -131.21 173.16 11.32 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.197 1.399 . . . . 0.0 111.172 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.6 p -103.14 175.71 5.39 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.306 -0.871 . . . . 0.0 112.017 163.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.66 131.97 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.132 2.173 . . . . 0.0 107.527 166.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -76.99 87.85 3.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.854 1.262 . . . . 0.0 110.535 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 94.0 p -61.89 -30.88 71.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.135 0.974 . . . . 0.0 112.884 -171.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.99 -25.1 67.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.32 2.61 31.62 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.432 1.493 . . . . 0.0 112.033 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 62.87 5.07 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 127.246 2.218 . . . . 0.0 111.355 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.7 -24.28 30.14 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.363 2.708 . . . . 0.0 112.456 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.22 -37.12 83.07 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.74 0.7 . . . . 0.0 112.216 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.0 tp -66.89 -48.57 68.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.076 0.55 . . . . 0.0 109.648 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.9 ttp -54.81 -45.32 74.37 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.81 0.844 . . . . 0.0 111.515 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -61.43 -52.46 64.49 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.328 1.451 . . . . 0.0 112.045 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -66.02 -20.31 66.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.65 -7.21 51.1 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.15 0.886 . . . . 0.0 112.991 169.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.51 17.19 24.75 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.269 1.414 . . . . 0.0 114.785 171.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -141.25 157.51 45.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.596 1.198 . . . . 0.0 113.734 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 31.37 0.32 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.521 1.128 . . . . 0.0 113.064 -161.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -130.87 -70.86 0.59 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -149.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.5 m -160.24 167.98 12.81 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 127.517 2.327 . . . . 0.0 109.783 -160.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.73 130.93 19.59 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.354 2.703 . . . . 0.0 112.161 168.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.9 m -145.81 142.37 28.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.018 0.927 . . . . 0.0 111.193 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.46 124.64 44.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.167 1.787 . . . . 0.0 108.322 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.5 t -118.13 129.63 74.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 124.432 1.093 . . . . 0.0 109.203 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.16 123.94 49.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.301 1.441 . . . . 0.0 110.056 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -105.54 138.46 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 126.051 1.741 . . . . 0.0 109.628 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -150.2 132.64 15.64 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.708 1.603 . . . . 0.0 109.242 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.01 19.07 11.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.813 1.245 . . . . 0.0 114.042 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.2 23.78 56.18 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.843 1.211 . . . . 0.0 113.488 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 163.45 32.66 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.691 1.196 . . . . 0.0 112.279 172.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.96 117.43 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.82 -35.2 24.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.105 0.962 . . . . 0.0 112.361 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -157.72 147.62 20.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.001 0.921 . . . . 0.0 112.77 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.35 128.92 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.055 1.742 . . . . 0.0 107.574 164.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -133.69 109.71 9.35 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.262 1.025 . . . . 0.0 110.873 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.5 p -103.1 81.03 1.92 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.812 1.245 . . . . 0.0 111.155 -175.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.97 -173.36 43.33 Favored Glycine 0 N--CA 1.469 0.839 0 C-N-CA 123.941 0.781 . . . . 0.0 114.092 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.68 146.91 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 125.842 1.657 . . . . 0.0 110.234 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -154.93 167.37 30.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.237 1.015 . . . . 0.0 113.598 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -99.51 159.17 30.72 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.871 2.868 . . . . 0.0 109.445 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.12 -38.71 54.29 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.627 2.218 . . . . 0.0 112.816 -167.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -58.55 -28.58 65.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.902 0.881 . . . . 0.0 112.951 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -76.97 -35.26 57.35 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.325 -0.859 . . . . 0.0 111.55 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.1 99.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.109 -0.994 . . . . 0.0 111.548 170.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -58.05 -44.71 87.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.962 0.905 . . . . 0.0 111.849 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.6 -37.36 79.74 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.1 mt -59.71 -51.6 69.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.894 0.77 . . . . 0.0 110.295 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.99 -51.27 69.95 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.92 -0.487 . . . . 0.0 112.08 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.3 -26.4 60.82 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.066 0.946 . . . . 0.0 112.406 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.1 m -89.16 -13.07 39.23 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.37 1.468 . . . . 0.0 110.057 169.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -68.16 173.14 4.94 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.969 -1.082 . . . . 0.0 113.245 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 11.89 3.85 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.213 1.405 . . . . 0.0 113.713 -162.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 39.2 mt -57.18 104.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 126.362 1.865 . . . . 0.0 110.57 -169.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.41 139.98 14.82 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.279 1.032 . . . . 0.0 111.928 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -40.61 111.87 0.24 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.382 2.673 . . . . 0.0 114.384 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.2 pt -119.49 34.83 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.2 1.4 . . . . 0.0 112.297 170.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 m -42.03 -34.79 0.76 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.473 1.909 . . . . 0.0 115.0 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -97.36 -16.42 20.26 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.238 1.815 . . . . 0.0 114.424 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -110.0 14.34 23.05 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.621 1.568 . . . . 0.0 113.358 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.14 21.6 16.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.671 1.588 . . . . 0.0 114.022 171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.89 148.43 41.43 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.475 1.036 . . . . 0.0 112.42 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.7 ptp -51.03 -30.79 16.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.73 1.212 . . . . 0.0 113.935 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.53 78.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.807 2.043 . . . . 0.0 115.503 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.88 -28.38 12.45 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.959 0.904 . . . . 0.0 111.869 171.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -58.82 -28.19 65.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.133 0.973 . . . . 0.0 112.658 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.0 -10.28 59.56 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.279 . . . . 0.0 112.678 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.5 -0.7 9.32 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 126.001 1.763 . . . . 0.0 113.868 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.59 170.21 13.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.324 1.062 . . . . 0.0 111.589 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.8 t -110.87 -50.71 2.92 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.033 0.933 . . . . 0.0 111.163 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.09 108.78 4.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.4 1.48 . . . . 0.0 108.704 -170.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.57 138.42 19.96 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.778 -0.577 . . . . 0.0 112.095 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.38 135.8 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.7 1.2 . . . . 0.0 109.682 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.47 128.69 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.056 0.931 . . . . 0.0 111.937 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -97.78 117.07 31.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.703 2.001 . . . . 0.0 110.154 175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -92.41 132.46 36.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.041 1.336 . . . . 0.0 111.043 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -155.99 166.95 31.96 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.928 0.891 . . . . 0.0 111.932 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -109.84 156.07 20.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.208 1.803 . . . . 0.0 109.57 169.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -20.23 46.63 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.499 -1.376 . . . . 0.0 113.858 170.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.38 85.88 2.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.159 1.784 . . . . 0.0 110.024 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.5 p -150.45 137.06 11.13 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.433 1.493 . . . . 0.0 110.804 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.94 -58.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.508 3.472 . . . . 0.0 112.562 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -74.4 -19.25 60.49 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.9 p -62.14 -17.69 58.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.547 1.139 . . . . 0.0 113.762 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -55.44 -46.26 76.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.389 1.076 . . . . 0.0 112.359 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -57.29 -41.66 80.2 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 0.0 112.486 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -52.7 -37.39 58.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.236 1.014 . . . . 0.0 112.849 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.76 -46.85 70.91 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.761 1.164 . . . . 0.0 110.9 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -37.24 81.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.478 0.711 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 m -84.64 -34.23 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.8 mt -68.38 -27.41 66.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.605 0.762 . . . . 0.0 111.922 171.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.66 -53.69 52.75 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.82 0.736 . . . . 0.0 110.656 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.06 -27.71 66.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.234 1.013 . . . . 0.0 112.811 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -70.3 -53.91 14.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.735 0.814 . . . . 0.0 111.522 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.64 -30.27 77.46 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.251 0.929 . . . . 0.0 112.851 -177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.01 67.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.638 1.175 . . . . 0.0 113.913 169.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -13.46 16.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.446 1.898 . . . . 0.0 113.418 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.86 75.83 38.1 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.08 1.752 . . . . 0.0 111.695 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -71.94 -31.34 12.7 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.825 3.016 . . . . 0.0 113.558 -172.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -71.04 -20.96 62.32 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.0 p -101.36 139.92 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.272 1.029 . . . . 0.0 110.19 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.14 119.43 37.84 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.074 0.95 . . . . 0.0 109.55 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -107.56 128.34 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.903 0.881 . . . . 0.0 110.036 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 68.6 m -137.38 169.39 17.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.408 1.083 . . . . 0.0 111.809 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 p -99.24 155.12 17.66 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.695 -1.253 . . . . 0.0 112.147 170.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 69.4 t -133.06 132.55 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.771 1.628 . . . . 0.0 110.307 170.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -74.96 97.17 3.3 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.979 0.895 . . . . 0.0 109.534 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -61.38 -28.57 69.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.748 0.819 . . . . 0.0 112.343 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.54 -24.73 65.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.066 1.347 . . . . 0.0 114.074 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.23 -11.45 52.35 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.868 0.758 . . . . 0.0 112.037 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.26 71.38 5.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.821 . . . . 0.0 112.541 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.84 -23.84 54.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.965 2.443 . . . . 0.0 112.501 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.09 -36.92 78.11 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.119 0.967 . . . . 0.0 112.29 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.99 -51.23 60.23 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.821 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.9 ttp -47.32 -47.57 25.55 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.042 0.937 . . . . 0.0 112.142 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -61.5 -54.15 47.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.298 1.039 . . . . 0.0 112.193 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.9 -25.4 64.58 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.3 tp -80.59 -5.52 56.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.936 1.694 . . . . 0.0 112.299 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 20.17 9.14 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 163.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -146.9 -178.54 6.24 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.247 1.524 . . . . 0.0 113.2 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -168.68 12.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -149.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -151.1 -154.37 0.54 Allowed 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.359 -0.838 . . . . 0.0 112.792 -142.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.3 m -46.25 157.78 0.41 Allowed Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.397 2.279 . . . . 0.0 113.682 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -52.94 141.2 57.01 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.01 3.14 . . . . 0.0 112.218 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 m -143.51 141.14 30.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.214 1.006 . . . . 0.0 111.192 -157.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.9 mt -100.51 122.64 43.56 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 125.846 1.659 . . . . 0.0 109.418 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.67 134.45 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.136 0.974 . . . . 0.0 110.122 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -117.23 123.82 47.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.321 1.848 . . . . 0.0 110.246 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.24 128.87 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.653 1.981 . . . . 0.0 109.353 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -147.11 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.122 1.369 . . . . 0.0 109.367 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.7 t0 76.04 24.44 1.18 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.317 2.247 . . . . 0.0 113.397 176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.21 21.31 62.93 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.554 -0.716 . . . . 0.0 113.235 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -143.86 164.52 30.31 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 112.452 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.57 116.95 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.77 -26.18 19.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.175 0.99 . . . . 0.0 113.576 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -156.55 147.58 22.06 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.148 0.886 . . . . 0.0 113.267 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.23 114.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.372 1.869 . . . . 0.0 106.899 166.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -115.13 110.91 20.23 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.516 1.126 . . . . 0.0 109.659 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 p -99.48 124.06 44.31 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.136 0.975 . . . . 0.0 111.58 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.55 -169.47 14.12 Favored Glycine 0 N--CA 1.472 1.075 0 C-N-CA 124.807 1.194 . . . . 0.0 114.01 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.3 mm -94.73 142.72 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.231 1.413 . . . . 0.0 111.225 -170.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.7 ptm -156.41 174.68 15.06 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.787 1.235 . . . . 0.0 113.052 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -119.25 156.44 52.74 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 127.495 2.318 . . . . 0.0 111.435 -168.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.85 -36.69 22.61 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.88 2.386 . . . . 0.0 113.382 -164.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -57.03 -35.33 69.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.107 0.963 . . . . 0.0 112.445 175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -82.16 -28.2 32.25 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.316 1.046 . . . . 0.0 112.186 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -45.13 95.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.828 0.851 . . . . 0.0 111.145 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -54.72 -49.81 69.86 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.212 1.405 . . . . 0.0 111.27 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.83 85.57 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.98 -46.16 91.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.826 1.25 . . . . 0.0 110.98 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -64.47 -50.1 68.79 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.57 -30.29 65.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -73.66 -20.63 60.51 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.473 0.706 0 C-N-CA 124.669 1.187 . . . . 0.0 111.671 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.878 0.847 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.2 p -86.19 158.95 19.63 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.233 1.413 . . . . 0.0 112.789 173.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.18 27.83 0.84 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.798 1.239 . . . . 0.0 113.096 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mt -70.51 94.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.2 1.4 . . . . 0.0 112.274 -158.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 155.72 29.64 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.395 1.878 . . . . 0.0 111.151 175.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.0 134.83 52.65 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.379 1.872 . . . . 0.0 113.963 -171.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.4 pt -123.95 26.35 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.839 1.255 . . . . 0.0 114.349 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.7 m -46.16 -38.83 8.75 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -76.9 -14.11 59.91 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.839 1.256 . . . . 0.0 114.052 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -116.18 8.86 14.5 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.47 1.908 . . . . 0.0 112.875 174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 16' ' ' PHE . . . -113.75 9.19 17.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.04 141.82 36.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.159 0.885 . . . . 0.0 111.241 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptm -53.22 -29.95 35.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.04 -54.36 25.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.823 1.649 . . . . 0.0 113.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.05 -28.2 19.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.231 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 11' ' ' ALA . 1.5 m-30 -57.83 -32.73 67.9 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.296 1.407 . . . . 0.0 113.475 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -81.62 7.83 11.3 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.607 1.163 . . . . 0.0 112.073 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.05 0.57 5.31 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 126.506 2.003 . . . . 0.0 114.102 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.49 -178.28 2.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.7 1.25 . . . . 0.0 112.619 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -111.92 -45.01 3.37 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.294 1.038 . . . . 0.0 110.906 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -161.46 122.23 2.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.453 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.51 138.37 17.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.315 1.046 . . . . 0.0 112.281 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.3 136.66 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.6 -1.313 . . . . 0.0 109.1 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.68 123.72 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 124.073 0.949 . . . . 0.0 110.836 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -96.52 113.06 24.6 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.476 1.11 . . . . 0.0 110.002 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -91.75 129.78 37.65 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.59 1.156 . . . . 0.0 110.897 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -158.87 164.62 35.54 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -174.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -108.09 149.4 28.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.644 2.378 . . . . 0.0 109.716 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -31.23 68.95 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.781 1.633 . . . . 0.0 114.657 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.0 mt -97.1 74.24 2.55 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.356 2.262 . . . . 0.0 109.162 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.8 t -161.4 97.6 1.29 Allowed Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.236 1.014 . . . . 0.0 111.971 -172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -58.65 -41.16 66.71 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.954 3.102 . . . . 0.0 113.153 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -69.44 -27.79 65.56 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 91.1 m -62.99 -24.74 68.05 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.434 1.494 . . . . 0.0 112.959 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -56.21 -45.44 79.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.673 1.189 . . . . 0.0 112.25 175.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -55.86 -42.4 75.79 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.673 1.189 . . . . 0.0 111.818 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -57.38 -41.69 80.67 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.251 -0.881 . . . . 0.0 112.317 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.38 -43.51 94.27 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.104 1.32 . . . . 0.0 110.665 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -42.06 94.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.93 0.492 . . . . 0.0 111.767 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG12 ' HD3' ' A' ' 94' ' ' PRO . 25.1 m -84.44 -33.85 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.44 -29.76 69.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.689 0.795 . . . . 0.0 112.128 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.16 -53.44 57.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.866 0.841 . . . . 0.0 111.609 173.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -65.76 -32.43 73.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.915 0.886 . . . . 0.0 112.354 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.41 -48.78 71.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.37 0.532 . . . . 0.0 111.666 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.48 -41.2 99.8 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.401 1.001 . . . . 0.0 112.07 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.16 -22.11 65.61 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -8.49 26.33 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.718 1.607 . . . . 0.0 112.975 173.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.05 64.4 33.58 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.528 1.531 . . . . 0.0 112.842 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.17 -27.81 86.03 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.598 3.532 . . . . 0.0 114.708 -171.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -70.39 -22.53 62.74 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.37 135.22 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.518 0.727 . . . . 0.0 110.185 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.68 124.13 43.3 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.004 0.922 . . . . 0.0 109.471 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.59 128.71 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.401 0.68 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 m -122.08 166.12 15.01 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.311 1.844 . . . . 0.0 111.39 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.4 p -131.22 132.69 44.84 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.946 -1.096 . . . . 0.0 112.392 165.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.3 t -114.85 139.32 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.087 1.755 . . . . 0.0 110.952 -170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -73.19 88.03 1.46 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.895 1.678 . . . . 0.0 110.808 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.2 p -62.25 -30.65 71.26 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.454 1.102 . . . . 0.0 112.685 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -56.02 -28.43 57.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.198 1.799 . . . . 0.0 113.789 173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.62 2.06 30.23 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.722 1.609 . . . . 0.0 112.256 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 60.62 5.03 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.609 1.964 . . . . 0.0 111.852 172.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.84 -26.9 31.69 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.772 2.981 . . . . 0.0 112.664 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.66 -38.08 76.97 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 118.808 0.731 . . . . 0.0 111.952 175.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.2 tp -67.16 -52.24 43.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 110.418 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -32.79 74.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -61.4 -46.75 88.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.373 -0.83 . . . . 0.0 112.503 169.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.15 -21.92 63.97 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.0 -9.93 59.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 168.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.1 22.0 11.18 Favored Glycine 0 N--CA 1.47 0.952 0 C-N-CA 124.865 1.221 . . . . 0.0 114.975 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.3 165.1 28.42 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.617 1.209 . . . . 0.0 112.38 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -170.51 55.14 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.237 1.415 . . . . 0.0 111.525 -167.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -154.57 -157.08 0.73 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.307 1.043 . . . . 0.0 112.65 -155.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.4 m -50.51 162.82 0.5 Allowed Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 127.352 2.261 . . . . 0.0 113.009 168.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.83 136.58 16.82 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.081 3.187 . . . . 0.0 113.217 173.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.9 m -139.12 133.35 31.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.979 0.912 . . . . 0.0 112.42 -165.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -98.51 110.8 23.33 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.361 2.264 . . . . 0.0 108.934 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -101.45 135.28 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.456 1.502 . . . . 0.0 109.65 175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -121.01 125.28 46.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.726 1.61 . . . . 0.0 110.536 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -108.25 139.1 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.838 2.055 . . . . 0.0 109.517 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -151.21 133.32 15.21 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.755 1.222 . . . . 0.0 110.171 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.5 17.14 10.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.664 1.586 . . . . 0.0 114.318 170.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.87 27.69 45.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.585 1.088 . . . . 0.0 112.824 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.56 162.08 33.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.289 1.036 . . . . 0.0 111.514 164.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -72.15 119.09 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 162.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.38 16.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.215 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -158.56 149.88 20.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.435 1.094 . . . . 0.0 112.787 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.38 124.09 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.451 1.501 . . . . 0.0 107.772 165.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -127.74 119.93 26.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.97 1.308 . . . . 0.0 111.073 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.8 p -108.55 108.94 20.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.029 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.23 -174.63 33.37 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.445 1.022 . . . . 0.0 114.229 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 mm -99.83 142.98 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.442 1.497 . . . . 0.0 110.246 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.4 mmt -139.71 167.34 22.33 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.84 160.18 28.28 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 125.11 1.364 . . . . 0.0 110.555 167.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD3' HG12 ' A' ' 40' ' ' VAL . 55.3 Cg_endo -63.08 -37.21 54.0 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.98 2.453 . . . . 0.0 113.972 -171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -57.47 -35.3 69.98 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.799 1.24 . . . . 0.0 112.268 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -86.45 -27.69 23.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.458 1.103 . . . . 0.0 112.033 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -41.35 98.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.0 0.818 . . . . 0.0 111.084 168.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -55.68 -47.34 76.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.226 . . . . 0.0 111.291 167.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.4 -37.5 85.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.751 0.705 . . . . 0.0 112.586 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.62 -39.61 80.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.035 1.334 . . . . 0.0 111.691 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -67.12 -46.75 73.19 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.495 -0.753 . . . . 0.0 111.978 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.07 -23.4 65.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.769 0.827 . . . . 0.0 112.789 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -75.83 -10.86 59.78 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.914 0.886 . . . . 0.0 112.995 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.473 0.708 0 C-N-CA 125.741 1.616 . . . . 0.0 108.687 169.325 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -162.63 154.49 18.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.018 1.727 . . . . 0.0 110.816 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.48 7.41 6.98 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.5 mt -69.02 102.17 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 0.0 111.403 -169.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -176.27 162.94 2.49 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 129.187 2.995 . . . . 0.0 110.119 169.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.2 143.08 56.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 -166.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.2 pt -135.66 32.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.912 1.285 . . . . 0.0 114.01 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.6 m -47.44 -35.87 9.16 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.613 -1.304 . . . . 0.0 114.408 -172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -78.75 -19.8 51.42 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.952 1.301 . . . . 0.0 113.66 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.97 12.54 23.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.697 1.599 . . . . 0.0 112.746 175.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.58 21.78 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.515 1.926 . . . . 0.0 113.22 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.27 146.53 37.81 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.247 0.927 . . . . 0.0 110.931 170.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.9 ptp -51.32 -31.95 23.49 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.475 1.11 . . . . 0.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.44 75.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.999 1.72 . . . . 0.0 115.298 -174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -102.65 -28.73 11.96 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.747 0.819 . . . . 0.0 111.454 172.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.43 -27.01 67.16 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.745 1.157 . . . . 0.0 112.697 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -72.87 -10.35 59.7 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.383 1.473 . . . . 0.0 113.294 173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.98 -0.55 10.7 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 126.342 1.925 . . . . 0.0 113.971 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -73.07 172.78 10.39 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.221 1.011 . . . . 0.0 111.633 174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 t -117.51 -38.21 3.35 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.039 0.936 . . . . 0.0 110.662 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -147.15 127.02 13.53 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.038 2.535 . . . . 0.0 108.821 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.72 145.7 17.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.138 0.975 . . . . 0.0 111.618 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.89 135.99 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.67 -1.268 . . . . 0.0 110.396 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.19 121.18 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.024 0.929 . . . . 0.0 110.421 176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -97.5 129.79 44.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.949 2.099 . . . . 0.0 109.832 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -102.88 130.86 50.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.478 1.111 . . . . 0.0 112.437 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -148.53 164.53 33.94 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.471 1.108 . . . . 0.0 112.999 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 30' ' ' LEU . 38.4 ttpt -144.7 150.75 37.83 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.73 2.012 . . . . 0.0 109.877 -175.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -20.07 3.53 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.723 1.609 . . . . 0.0 115.045 175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 37.7 mt -103.95 5.87 35.87 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.144 1.778 . . . . 0.0 114.932 -175.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.2 101.77 21.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.732 0.813 . . . . 0.0 111.074 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.85 -30.18 27.24 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.514 2.143 . . . . 0.0 112.323 174.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -68.38 -20.28 64.68 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.2 m -59.12 -24.65 63.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.971 1.309 . . . . 0.0 113.988 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -50.48 -48.77 56.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.326 1.051 . . . . 0.0 112.279 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -57.09 -42.3 80.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.7 1.2 . . . . 0.0 112.689 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -59.89 -41.67 92.13 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.627 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.43 -44.62 96.81 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.08 1.309 . . . . 0.0 110.858 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -44.3 94.65 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.618 0.767 . . . . 0.0 111.483 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -82.29 -33.91 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -68.04 -30.25 69.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.738 0.815 . . . . 0.0 111.989 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.17 -52.34 59.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.846 0.858 . . . . 0.0 111.009 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.46 -25.47 64.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.037 0.935 . . . . 0.0 112.826 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.3 -51.75 34.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.077 0.951 . . . . 0.0 110.767 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.37 94.29 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.847 1.213 . . . . 0.0 112.57 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.3 66.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.946 1.298 . . . . 0.0 113.784 172.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -16.17 17.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.127 1.771 . . . . 0.0 113.039 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.24 71.65 45.59 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.254 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.62 -30.53 34.81 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.807 3.005 . . . . 0.0 113.948 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -71.55 -18.87 62.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.78 138.89 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.51 1.124 . . . . 0.0 110.951 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.61 136.5 41.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.924 1.289 . . . . 0.0 109.952 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.27 131.87 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.266 1.027 . . . . 0.0 110.181 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 m -134.38 147.37 50.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.955 1.302 . . . . 0.0 112.157 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 84.5 p -109.12 105.38 14.83 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.491 -1.381 . . . . 0.0 112.393 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.04 130.83 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.267 1.827 . . . . 0.0 111.286 -173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -70.8 91.89 0.86 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.1 p -60.69 -25.88 66.71 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 113.211 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.1 -27.81 69.65 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -100.18 -21.21 15.61 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.836 1.255 . . . . 0.0 111.297 176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -112.09 53.98 0.43 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 127.439 2.295 . . . . 0.0 112.419 173.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.24 -28.91 33.24 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.028 1.819 . . . . 0.0 112.849 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.39 -33.07 66.92 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.922 0.889 . . . . 0.0 112.388 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.9 tp -69.05 -49.07 60.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.457 0.703 . . . . 0.0 110.819 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -59.0 -38.13 78.49 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.242 0.928 . . . . 0.0 112.393 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -62.79 -50.97 68.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.132 0.973 . . . . 0.0 111.983 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -67.65 -31.6 71.71 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -65.78 -8.98 24.42 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.089 0.956 . . . . 0.0 113.139 167.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.67 22.6 18.05 Favored Glycine 0 N--CA 1.468 0.777 0 C-N-CA 124.768 1.175 . . . . 0.0 114.76 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -143.8 161.19 39.27 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -169.68 37.16 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.422 1.489 . . . . 0.0 111.574 -161.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.71 -153.17 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 112.383 -155.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.7 m -53.99 154.09 8.01 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 124.798 1.239 . . . . 0.0 111.44 170.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.13 144.74 79.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.673 2.916 . . . . 0.0 113.131 -176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 37.0 m -141.19 139.32 33.82 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.204 1.002 . . . . 0.0 111.214 -158.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.96 135.13 40.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.826 2.051 . . . . 0.0 109.183 171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -124.58 132.91 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.146 0.979 . . . . 0.0 110.159 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.98 127.26 54.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 126.121 1.768 . . . . 0.0 110.398 -172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mm -103.56 133.66 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.652 1.981 . . . . 0.0 108.673 172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.84 130.04 16.54 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.735 1.214 . . . . 0.0 109.948 173.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t0 68.64 22.03 7.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.717 1.607 . . . . 0.0 113.231 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.71 58.12 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.3 0.952 . . . . 0.0 113.923 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 164.12 31.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.177 0.991 . . . . 0.0 112.313 173.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -73.08 115.4 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.52 -25.28 21.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.792 1.237 . . . . 0.0 112.611 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -159.7 146.32 16.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.059 0.943 . . . . 0.0 113.166 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.95 118.86 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 161.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -118.71 114.04 22.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.769 1.228 . . . . 0.0 110.117 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.1 t -106.02 123.21 47.63 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.117 0.967 . . . . 0.0 110.581 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.56 -169.72 16.59 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.008 1.29 . . . . 0.0 114.537 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.1 mm -97.0 145.94 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.337 1.455 . . . . 0.0 110.794 -171.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 mmt -141.08 164.03 31.38 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.481 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -109.5 153.13 43.0 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 128.239 2.616 . . . . 0.0 109.365 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.51 -40.3 10.73 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.364 2.043 . . . . 0.0 112.556 -162.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -57.2 -32.58 66.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.798 1.239 . . . . 0.0 112.407 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -87.14 -26.7 23.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.645 1.178 . . . . 0.0 112.542 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -42.78 94.37 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.458 1.026 . . . . 0.0 111.153 168.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -57.82 -44.01 86.13 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 111.717 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.89 -45.71 67.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.778 0.831 . . . . 0.0 112.689 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.2 tp -55.19 -40.55 70.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.187 1.795 . . . . 0.0 111.241 176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -72.19 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.162 0.985 . . . . 0.0 113.585 173.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.49 68.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.078 0.551 . . . . 0.0 112.146 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -71.4 -11.28 60.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 125.117 1.367 . . . . 0.0 109.124 170.564 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -72.27 62.63 0.5 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.245 1.818 . . . . 0.0 112.412 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.77 3.88 21.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.774 1.629 . . . . 0.0 113.386 -164.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 97.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.033 1.733 . . . . 0.0 111.08 -162.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.06 22.31 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.246 1.418 . . . . 0.0 110.81 -178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -49.14 120.79 4.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.181 1.792 . . . . 0.0 113.8 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.14 39.19 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.352 1.061 . . . . 0.0 112.914 173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 m -35.38 -39.74 0.13 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.709 2.003 . . . . 0.0 115.39 173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 t -95.16 -14.12 24.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.537 1.935 . . . . 0.0 114.613 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -116.16 11.14 15.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.693 1.597 . . . . 0.0 113.441 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -112.84 26.32 10.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.444 1.497 . . . . 0.0 113.345 170.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.19 146.63 36.53 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.475 1.036 . . . . 0.0 111.39 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.8 ptp -52.83 -31.94 41.73 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.478 1.111 . . . . 0.0 113.631 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.29 -52.75 51.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.526 1.93 . . . . 0.0 113.765 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -27.91 19.82 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.452 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -58.12 -29.9 65.88 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.881 1.219 . . . . 0.0 113.26 172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.67 -7.19 51.06 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.087 1.355 . . . . 0.0 112.953 172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.31 -0.11 11.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.349 1.928 . . . . 0.0 113.813 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.4 179.4 5.87 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.378 1.089 . . . . 0.0 111.624 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -131.03 -35.35 1.39 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.293 1.037 . . . . 0.0 111.592 177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -143.5 125.56 15.36 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 127.032 2.133 . . . . 0.0 108.681 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.91 132.57 6.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.287 0.635 . . . . 0.0 111.297 170.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -114.0 132.08 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 120.804 -1.185 . . . . 0.0 109.254 168.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 129.18 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.835 0.826 . . . . 0.0 111.351 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.41 114.84 29.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.453 1.901 . . . . 0.0 110.03 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -89.48 129.46 35.97 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.659 1.184 . . . . 0.0 110.871 -176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -160.02 175.14 13.34 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.449 1.5 . . . . 0.0 110.028 -172.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' H ' ' A' ' 30' ' ' LEU . 18.9 ptpt -149.07 178.68 8.5 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.12 176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.63 -20.2 31.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 114.474 173.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.439 ' H ' ' HG3' ' A' ' 28' ' ' LYS . 80.1 mt -116.4 82.75 1.84 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.377 1.471 . . . . 0.0 110.571 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.9 p -158.73 130.1 3.89 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.751 1.22 . . . . 0.0 112.296 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.15 -42.58 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.143 3.229 . . . . 0.0 112.33 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -73.39 -22.72 60.18 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -172.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.9 p -56.19 -25.89 48.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 113.738 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -48.15 -46.95 35.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.618 1.567 . . . . 0.0 112.967 170.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 21.1 m-80 -65.74 -35.0 79.5 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.247 1.019 . . . . 0.0 112.155 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -64.01 -33.95 76.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.056 1.342 . . . . 0.0 112.268 174.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -65.19 -44.98 86.65 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.497 1.044 . . . . 0.0 110.638 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -61.72 -42.73 99.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.576 0.75 . . . . 0.0 111.673 -176.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.96 -39.29 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -69.57 -30.83 68.71 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.02 -50.05 72.2 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.878 0.871 . . . . 0.0 110.404 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.07 -25.12 61.65 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.823 . . . . 0.0 112.627 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -70.66 -51.17 29.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.385 0.674 . . . . 0.0 111.335 169.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.41 98.11 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.605 1.098 . . . . 0.0 111.927 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.47 -23.98 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 173.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.42 23.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.615 1.566 . . . . 0.0 112.904 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.78 61.59 23.63 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 125.696 1.598 . . . . 0.0 112.951 -176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -56.81 -28.73 78.06 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 125.24 3.96 . . . . 0.0 114.368 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -73.17 -20.13 60.96 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 t -86.98 130.5 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.662 1.185 . . . . 0.0 108.532 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.62 112.76 24.71 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.97 126.82 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 122.798 0.439 . . . . 0.0 110.391 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.2 m -130.88 165.96 21.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.759 1.223 . . . . 0.0 111.142 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 p -89.7 163.72 15.0 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 120.91 -1.119 . . . . 0.0 111.082 160.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.78 125.78 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 108.6 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.39 90.58 2.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.8 p -58.55 -24.64 61.19 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.569 1.548 . . . . 0.0 112.882 -175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.08 -24.94 67.41 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.966 1.306 . . . . 0.0 114.407 172.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -90.16 -18.68 25.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.007 0.821 . . . . 0.0 110.9 172.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -118.36 44.5 0.54 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 126.386 1.874 . . . . 0.0 112.408 -174.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.78 -23.96 41.23 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.005 2.47 . . . . 0.0 114.179 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -39.25 26.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.45 1.1 . . . . 0.0 111.552 172.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.23 -46.83 85.12 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.532 0.733 . . . . 0.0 110.795 174.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 43.8 ttp -47.59 -52.02 19.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.257 1.423 . . . . 0.0 111.852 169.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -64.75 -44.47 89.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.335 0.654 . . . . 0.0 112.354 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.01 -21.56 61.54 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -70.85 -9.65 58.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.308 1.043 . . . . 0.0 112.603 166.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.57 20.95 30.38 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 124.553 1.073 . . . . 0.0 113.514 172.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -138.76 161.91 36.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.429 1.114 . . . . 0.0 113.472 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -172.6 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.799 1.64 . . . . 0.0 110.992 -167.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -154.28 -148.77 0.25 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.99 1.316 . . . . 0.0 112.102 -157.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.9 m -49.53 155.09 1.42 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 125.81 1.644 . . . . 0.0 113.153 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.11 144.52 28.6 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.459 3.439 . . . . 0.0 112.539 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -139.5 136.68 34.8 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.777 0.831 . . . . 0.0 111.86 -160.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.7 mt -94.04 128.04 40.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.85 1.66 . . . . 0.0 109.759 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.98 135.44 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.593 1.157 . . . . 0.0 109.966 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -122.72 125.05 44.77 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.493 1.517 . . . . 0.0 111.01 -169.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mm -108.91 131.3 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.564 1.945 . . . . 0.0 109.318 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -146.54 132.79 19.45 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.578 1.551 . . . . 0.0 109.739 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 59.59 19.38 7.94 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.568 1.947 . . . . 0.0 114.945 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.44 21.64 50.69 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.133 0.873 . . . . 0.0 113.321 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.62 162.89 33.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.162 0.985 . . . . 0.0 112.548 172.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -76.92 113.44 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.76 -35.11 33.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.406 1.083 . . . . 0.0 113.194 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -155.89 149.01 24.45 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.5 t -130.34 112.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.044 2.138 . . . . 0.0 106.794 167.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -118.41 106.53 12.82 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.419 1.488 . . . . 0.0 111.107 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 p -95.17 100.76 12.52 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.793 1.237 . . . . 0.0 110.078 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.9 179.08 37.24 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 124.185 0.898 . . . . 0.0 113.861 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.57 144.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.889 1.275 . . . . 0.0 111.134 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.6 mtt -125.82 165.89 17.84 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.135 1.374 . . . . 0.0 113.643 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -107.81 154.29 41.07 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 127.384 2.274 . . . . 0.0 108.291 154.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.99 -35.49 65.65 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.446 2.097 . . . . 0.0 113.567 -159.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -56.58 -28.86 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -72.84 -35.57 67.27 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.379 0.671 . . . . 0.0 111.466 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -45.63 92.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.523 1.129 . . . . 0.0 110.819 172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -45.94 90.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.151 0.98 . . . . 0.0 111.439 173.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.76 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.89 -46.55 87.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.768 0.827 . . . . 0.0 111.163 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -57.73 -52.13 66.72 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.23 -0.919 . . . . 0.0 112.006 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.92 -26.27 65.8 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.027 0.531 . . . . 0.0 112.22 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.8 t -78.31 -31.61 48.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.577 0.751 . . . . 0.0 112.153 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.459 1.104 . . . . 0.0 111.833 179.436 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.13 0.491 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 t -154.09 170.82 20.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.386 1.075 . . . . 0.0 111.623 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.62 15.05 5.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.027 1.331 . . . . 0.0 113.155 -161.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 52.9 mt -61.69 103.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.968 1.307 . . . . 0.0 111.37 -167.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -161.77 154.84 20.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.323 2.649 . . . . 0.0 109.16 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -54.3 120.51 6.64 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.261 2.224 . . . . 0.0 112.824 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.3 pt -121.86 30.1 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.3 m -46.56 -31.07 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.643 1.177 . . . . 0.0 114.059 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -75.67 -23.51 56.25 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.788 1.635 . . . . 0.0 113.231 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -132.8 21.23 4.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.604 1.162 . . . . 0.0 113.459 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.3 23.3 12.56 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.459 1.903 . . . . 0.0 114.013 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.11 144.09 35.69 Favored Glycine 0 N--CA 1.465 0.597 0 O-C-N 121.402 -0.812 . . . . 0.0 111.468 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptm -50.09 -31.98 14.58 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.682 1.193 . . . . 0.0 113.636 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.65 -35.0 67.88 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.596 1.958 . . . . 0.0 115.645 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -108.76 -26.03 10.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 111.577 173.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -60.06 -26.2 65.97 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.301 0.955 . . . . 0.0 112.503 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.22 -8.61 57.08 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.228 1.411 . . . . 0.0 113.14 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.21 -2.55 13.58 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.359 1.933 . . . . 0.0 113.531 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.09 173.63 9.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.138 0.969 . . . . 0.0 112.058 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -117.91 -32.37 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.305 1.442 . . . . 0.0 111.514 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -163.17 118.54 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.103 2.161 . . . . 0.0 108.96 -172.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.45 141.01 15.7 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.958 1.303 . . . . 0.0 111.518 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.18 137.56 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.96 124.65 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.651 0.781 . . . . 0.0 111.164 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -102.79 113.88 27.68 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.773 1.629 . . . . 0.0 111.762 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -91.69 133.69 35.37 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.634 1.973 . . . . 0.0 110.745 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -154.93 159.49 40.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.768 0.827 . . . . 0.0 111.969 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -86.54 157.53 19.73 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.128 1.371 . . . . 0.0 110.416 169.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -19.76 66.12 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -123.0 92.16 3.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.172 1.789 . . . . 0.0 108.109 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.3 p -146.51 131.14 8.81 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.34 1.456 . . . . 0.0 111.343 173.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.37 -50.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.072 3.181 . . . . 0.0 112.788 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -70.96 -30.36 66.62 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -54.29 -24.46 19.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.263 1.825 . . . . 0.0 114.24 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -50.05 -46.09 52.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.697 1.599 . . . . 0.0 111.883 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -65.39 -33.48 76.05 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.772 -1.205 . . . . 0.0 112.146 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.2 ttm -64.01 -34.53 78.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.023 1.729 . . . . 0.0 112.118 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.32 -45.21 81.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.94 0.791 . . . . 0.0 110.55 168.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -42.77 97.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 111.538 -173.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.48 -38.82 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.71 -29.53 65.84 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.749 0.82 . . . . 0.0 113.2 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.64 -51.44 42.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.208 1.003 . . . . 0.0 110.95 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -71.16 -20.76 62.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.383 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -72.66 -53.1 12.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.928 1.291 . . . . 0.0 111.311 166.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -56.29 -36.76 70.34 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.492 1.044 . . . . 0.0 112.245 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.99 -31.22 62.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.298 1.439 . . . . 0.0 114.015 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -9.32 17.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.661 1.584 . . . . 0.0 113.605 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.06 71.18 32.02 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.774 1.63 . . . . 0.0 111.871 -175.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.93 -30.04 26.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 124.111 3.207 . . . . 0.0 113.78 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -72.33 -19.91 61.57 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -106.53 144.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.804 1.242 . . . . 0.0 110.67 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.82 131.52 53.82 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.996 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.03 125.9 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.385 0.674 . . . . 0.0 109.602 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 70.3 m -122.26 177.22 5.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.535 1.134 . . . . 0.0 111.619 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.9 p -113.28 174.48 5.89 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.818 -1.176 . . . . 0.0 112.796 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.9 t -148.19 135.21 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 128.288 2.635 . . . . 0.0 108.33 171.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.34 89.55 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.287 1.035 . . . . 0.0 110.488 168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.4 p -58.2 -34.35 70.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.762 1.225 . . . . 0.0 112.864 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.27 -23.21 65.66 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.158 0.983 . . . . 0.0 113.148 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.49 0.67 53.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.396 1.478 . . . . 0.0 112.823 176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 64.88 7.06 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 127.416 2.286 . . . . 0.0 111.082 172.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.89 -17.06 20.16 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.866 3.044 . . . . 0.0 113.982 -173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -36.55 39.76 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.401 1.001 . . . . 0.0 111.293 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.77 -53.22 57.69 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 110.416 176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.77 73.0 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -64.52 -41.55 96.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.777 0.831 . . . . 0.0 112.656 170.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -75.74 -22.97 56.0 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.19 -25.89 67.91 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.489 1.04 . . . . 0.0 111.825 163.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.49 23.41 4.43 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.121 1.208 . . . . 0.0 116.121 167.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.86 172.04 13.45 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.439 1.119 . . . . 0.0 112.308 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -162.44 35.63 0.11 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.029 0.932 . . . . 0.0 112.665 -163.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -143.72 -158.67 0.9 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.096 1.358 . . . . 0.0 112.99 -153.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.45 162.66 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 127.674 2.39 . . . . 0.0 112.792 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -45.48 141.88 7.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.7 3.6 . . . . 0.0 113.735 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 53.8 m -148.26 136.41 21.17 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.511 1.124 . . . . 0.0 109.917 -163.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -109.85 138.82 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.676 0.791 . . . . 0.0 110.557 172.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -127.91 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.709 1.604 . . . . 0.0 109.97 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -115.25 140.39 49.13 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.058 1.743 . . . . 0.0 112.129 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mm -112.59 141.24 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.879 2.071 . . . . 0.0 110.114 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 tpt85 -147.22 119.7 8.47 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.625 2.37 . . . . 0.0 108.552 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 56.75 24.38 8.99 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.43 23.31 37.37 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.129 -0.982 . . . . 0.0 114.105 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 164.85 28.97 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.544 1.138 . . . . 0.0 112.406 169.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.67 116.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.55 -43.28 56.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.09 0.956 . . . . 0.0 112.5 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -159.02 147.27 18.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.102 0.561 . . . . 0.0 112.151 -165.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.1 t -126.77 121.48 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.314 1.846 . . . . 0.0 106.788 167.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -130.18 119.13 22.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.836 0.854 . . . . 0.0 111.45 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -105.96 88.7 2.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.202 1.401 . . . . 0.0 111.218 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.29 162.47 26.0 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.19 147.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.14 1.776 . . . . 0.0 109.43 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -155.2 -160.75 1.08 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.489 1.115 . . . . 0.0 112.141 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.23 160.58 40.77 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.601 1.56 . . . . 0.0 109.819 166.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.19 -35.07 66.05 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 113.46 -169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -55.49 -31.91 62.4 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.422 1.089 . . . . 0.0 113.007 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -79.18 -31.65 43.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.891 0.876 . . . . 0.0 111.468 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -43.3 96.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.621 0.769 . . . . 0.0 110.764 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.03 -47.31 81.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.091 0.956 . . . . 0.0 111.585 171.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.14 -40.85 90.93 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.22 -44.6 94.82 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.472 1.109 . . . . 0.0 111.365 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -66.53 -46.73 75.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.365 -0.835 . . . . 0.0 112.452 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.59 64.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.474 0.71 . . . . 0.0 112.293 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -73.75 -20.06 60.61 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.508 0.723 . . . . 0.0 112.533 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 125.417 1.487 . . . . 0.0 111.548 176.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -158.84 166.24 32.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.925 1.69 . . . . 0.0 111.448 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 13.53 4.19 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.441 1.096 . . . . 0.0 113.455 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' SER . 19.6 mt -74.82 80.35 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.682 1.193 . . . . 0.0 110.653 -169.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -129.52 146.74 51.31 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 127.267 2.227 . . . . 0.0 109.296 -176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.48 95.56 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.392 2.277 . . . . 0.0 111.525 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.52 28.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.616 1.566 . . . . 0.0 111.365 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -37.97 -42.48 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.527 2.731 . . . . 0.0 113.912 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 t -91.39 -25.97 19.11 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.335 1.454 . . . . 0.0 114.503 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -91.59 6.85 44.12 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.69 1.596 . . . . 0.0 112.915 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.68 22.64 15.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.667 1.587 . . . . 0.0 114.363 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.22 142.74 41.71 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 121.096 -1.003 . . . . 0.0 111.566 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.5 ptm -52.96 -30.74 36.65 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.71 -53.3 25.47 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.375 1.87 . . . . 0.0 114.272 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -24.59 18.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.179 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -63.4 -25.09 68.12 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.498 1.045 . . . . 0.0 113.357 172.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.61 -4.01 43.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.739 1.216 . . . . 0.0 112.733 169.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.49 -1.89 13.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.395 1.95 . . . . 0.0 113.783 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.5 179.74 5.1 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.278 1.031 . . . . 0.0 112.406 175.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -124.89 -34.66 2.78 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.186 1.394 . . . . 0.0 110.506 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -153.87 144.67 22.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.237 2.215 . . . . 0.0 109.464 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.99 137.01 3.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 110.229 168.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.72 132.71 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 119.923 -1.736 . . . . 0.0 108.542 164.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -130.85 117.29 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.895 1.278 . . . . 0.0 111.066 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.86 112.76 24.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.439 1.495 . . . . 0.0 110.464 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -85.42 129.56 34.79 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.366 1.466 . . . . 0.0 110.207 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -152.33 179.13 8.82 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.144 0.978 . . . . 0.0 111.731 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -128.57 145.68 51.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.786 2.035 . . . . 0.0 108.67 173.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.94 -30.62 64.18 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.145 1.778 . . . . 0.0 114.266 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.8 mt -107.78 88.56 2.76 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.228 1.811 . . . . 0.0 108.048 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.8 t -159.24 116.59 1.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.078 1.351 . . . . 0.0 111.161 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -77.28 -37.67 0.96 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.59 2.86 . . . . 0.0 112.499 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -73.91 -28.88 61.75 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.111 0.868 . . . . 0.0 113.199 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -54.67 -28.57 48.28 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.622 1.969 . . . . 0.0 113.738 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -53.03 -47.44 68.35 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.91 1.284 . . . . 0.0 111.814 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -61.24 -40.02 92.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.628 1.171 . . . . 0.0 112.16 -173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -57.22 -39.61 75.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.598 1.159 . . . . 0.0 112.145 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -65.89 -43.53 87.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.922 1.237 . . . . 0.0 110.918 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -37.14 82.7 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.982 0.513 . . . . 0.0 112.11 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.44 -33.44 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.5 mt -64.87 -31.92 73.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.659 0.784 . . . . 0.0 111.88 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -61.28 -53.35 57.89 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.021 0.915 . . . . 0.0 111.466 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -69.06 -24.38 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.593 1.157 . . . . 0.0 112.567 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -73.55 -50.23 22.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.655 0.782 . . . . 0.0 111.858 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.43 -37.72 94.56 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 124.617 1.103 . . . . 0.0 112.728 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.13 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.778 1.231 . . . . 0.0 114.152 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 -12.69 18.57 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.135 1.774 . . . . 0.0 112.934 175.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.86 55.62 13.24 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.882 1.673 . . . . 0.0 113.319 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -60.55 -27.69 85.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 124.869 3.712 . . . . 0.0 114.297 -164.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -70.68 -19.68 62.76 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.25 143.66 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.58 1.152 . . . . 0.0 110.286 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.61 121.64 44.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.93 121.22 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ILE . 16.5 m -124.72 175.58 7.13 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.126 1.37 . . . . 0.0 109.932 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 p -112.03 166.29 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.221 -1.55 . . . . 0.0 113.478 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -136.94 133.32 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.675 1.59 . . . . 0.0 109.804 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -73.61 93.84 2.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.552 1.141 . . . . 0.0 110.079 170.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.8 p -61.39 -26.79 68.08 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.413 -0.804 . . . . 0.0 112.792 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.07 -27.14 68.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.005 1.722 . . . . 0.0 113.585 173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.2 -20.76 22.66 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.107 0.963 . . . . 0.0 112.481 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.23 76.73 18.59 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.61 1.164 . . . . 0.0 111.872 171.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.15 -21.22 48.92 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.955 2.437 . . . . 0.0 111.97 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.82 -38.85 83.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.697 0.799 . . . . 0.0 112.362 171.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.1 tp -68.66 -47.34 66.8 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.239 0.616 . . . . 0.0 110.503 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.473 ' HG3' ' CE2' ' A' ' 70' ' ' PHE . 57.3 ttp -49.15 -48.63 44.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.934 1.294 . . . . 0.0 111.827 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.32 -50.12 71.26 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.891 1.276 . . . . 0.0 111.888 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -66.89 -24.81 66.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.94 -21.94 63.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.595 1.089 . . . . 0.0 112.903 167.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.25 20.34 6.32 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.002 1.287 . . . . 0.0 115.701 168.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CE2' ' HG3' ' A' ' 65' ' ' MET . 37.0 p90 -138.45 166.67 23.67 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.857 1.329 . . . . 0.0 113.255 -177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.66 49.72 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.262 1.425 . . . . 0.0 111.971 -164.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -155.97 -156.86 0.67 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.66 1.184 . . . . 0.0 112.393 -155.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.2 m -49.22 158.49 0.72 Allowed Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 127.074 2.15 . . . . 0.0 112.842 170.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.3 143.99 62.46 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.963 3.108 . . . . 0.0 112.813 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.0 m -142.71 139.19 31.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.516 0.674 . . . . 0.0 111.477 -158.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.35 110.18 22.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.411 1.885 . . . . 0.0 109.1 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.408 ' HB ' HG23 ' A' ' 24' ' ' VAL . 49.8 t -102.8 135.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.13 1.372 . . . . 0.0 108.911 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -118.93 122.94 43.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.272 1.429 . . . . 0.0 109.51 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mm -107.01 139.13 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.602 1.961 . . . . 0.0 108.877 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.56 137.79 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.699 1.6 . . . . 0.0 110.301 177.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.2 t70 61.96 17.88 9.37 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.669 1.588 . . . . 0.0 114.27 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.26 25.58 59.09 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 124.902 1.239 . . . . 0.0 113.336 -174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.534 1.534 . . . . 0.0 112.0 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.12 116.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 170.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.66 -30.06 25.16 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.101 1.361 . . . . 0.0 112.959 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -163.83 151.08 12.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.114 1.365 . . . . 0.0 112.426 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -135.32 118.99 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.456 1.502 . . . . 0.0 108.263 167.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -117.32 114.95 24.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.896 1.279 . . . . 0.0 110.425 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 p -99.64 131.18 45.8 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.201 1.001 . . . . 0.0 111.754 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.67 -172.23 14.14 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.264 1.411 . . . . 0.0 113.973 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.62 144.21 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.948 1.299 . . . . 0.0 110.653 -174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.8 ptm -158.42 172.71 17.84 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -113.28 155.34 44.67 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 129.306 3.042 . . . . 0.0 110.792 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.29 -40.37 32.66 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.125 2.55 . . . . 0.0 112.586 -166.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -59.65 -27.8 66.68 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.96 0.904 . . . . 0.0 113.223 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -80.43 -29.56 37.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.598 0.759 . . . . 0.0 111.826 172.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.14 -41.36 97.22 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.247 0.931 . . . . 0.0 110.737 169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -40.82 75.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.517 0.727 . . . . 0.0 110.92 170.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.96 83.23 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.4 mt -60.75 -42.83 98.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.708 1.14 . . . . 0.0 111.424 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -68.64 -50.84 48.15 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.55 -33.35 68.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.049 0.94 . . . . 0.0 112.742 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.8 p -81.79 -9.13 59.7 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.528 0.731 . . . . 0.0 112.929 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 159.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m -64.81 164.15 12.86 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.999 1.72 . . . . 0.0 113.807 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.4 26.06 1.32 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 113.417 -167.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.36 91.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.634 1.174 . . . . 0.0 110.539 -170.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.65 143.04 46.12 Favored 'General case' 0 C--O 1.218 -0.589 0 C-N-CA 126.984 2.113 . . . . 0.0 107.867 172.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -67.6 101.99 1.1 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 111.053 169.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.8 pt -111.08 34.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.222 1.409 . . . . 0.0 112.334 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.8 m -44.06 -31.1 0.85 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.578 2.351 . . . . 0.0 114.598 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -99.47 -15.42 18.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.952 1.701 . . . . 0.0 114.549 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -112.68 17.32 19.21 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.768 1.627 . . . . 0.0 113.006 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.93 27.39 9.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.098 1.359 . . . . 0.0 113.737 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.28 149.93 39.7 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.02 1.295 . . . . 0.0 112.13 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.0 ptm -52.52 -29.77 26.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.845 1.258 . . . . 0.0 113.592 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.86 -36.54 81.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.767 2.027 . . . . 0.0 115.577 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -26.17 13.93 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.774 0.829 . . . . 0.0 112.172 170.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -60.57 -26.61 67.07 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.402 1.081 . . . . 0.0 113.431 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -74.34 -7.71 53.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.743 1.217 . . . . 0.0 112.848 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.53 0.08 11.2 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 127.148 2.308 . . . . 0.0 113.743 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.33 171.13 15.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.404 1.102 . . . . 0.0 110.998 173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 m -116.36 -39.22 3.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.953 1.301 . . . . 0.0 110.217 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -157.47 130.07 7.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.321 2.648 . . . . 0.0 108.317 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.97 145.09 13.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.418 . . . . 0.0 110.978 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.92 142.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.564 -1.335 . . . . 0.0 109.198 162.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.88 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 121.666 0.746 . . . . 0.0 111.594 172.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -98.27 102.55 14.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.381 2.272 . . . . 0.0 110.199 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.46 136.66 33.02 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 111.039 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -160.96 163.19 31.97 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.49 1.116 . . . . 0.0 112.038 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -97.75 150.75 20.88 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.656 1.582 . . . . 0.0 108.962 164.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.65 -25.34 6.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.244 1.817 . . . . 0.0 115.316 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -91.73 1.93 56.83 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 30.6 p -61.84 129.97 92.07 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 126.555 1.942 . . . . 0.0 114.385 -169.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.86 -47.38 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 125.122 3.881 . . . . 0.0 112.573 166.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -71.8 -26.87 62.59 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.158 -0.964 . . . . 0.0 113.521 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.0 p -55.97 -25.7 44.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.32 1.448 . . . . 0.0 113.409 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -56.62 -51.49 68.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.918 1.287 . . . . 0.0 112.433 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.7 -33.43 74.88 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.829 -1.795 . . . . 0.0 111.397 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.3 ttm -59.88 -47.63 84.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.464 1.906 . . . . 0.0 113.173 173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -68.96 -31.51 70.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.517 1.053 . . . . 0.0 111.658 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -46.23 89.78 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.258 -0.901 . . . . 0.0 111.778 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -71.76 -41.4 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.728 HD13 HG21 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -67.66 -36.57 80.99 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.463 0.574 . . . . 0.0 111.664 -178.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.89 -53.7 52.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.475 0.71 . . . . 0.0 111.269 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -64.92 -22.95 67.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.599 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -73.63 -51.68 15.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.163 1.385 . . . . 0.0 111.7 169.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.5 -32.96 79.58 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 124.97 1.272 . . . . 0.0 113.265 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.78 68.44 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.388 1.475 . . . . 0.0 113.62 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -6.56 18.77 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.831 1.652 . . . . 0.0 113.566 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.92 60.95 49.03 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 125.823 1.649 . . . . 0.0 113.02 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -55.52 -31.19 77.52 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.966 3.777 . . . . 0.0 114.597 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.01 -20.69 63.26 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.7 t -88.06 129.8 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.706 1.203 . . . . 0.0 108.12 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.9 122.9 39.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.728 HG21 HD13 ' A' ' 41' ' ' LEU . 2.1 mp -115.55 118.01 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 172.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m -122.94 161.58 23.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.148 1.379 . . . . 0.0 109.865 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.9 p -95.51 157.57 15.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.161 -1.587 . . . . 0.0 112.84 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -136.45 136.12 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.157 1.383 . . . . 0.0 110.538 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -81.03 86.83 6.07 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.527 1.131 . . . . 0.0 110.894 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.2 p -55.22 -24.87 29.68 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 120.846 -1.159 . . . . 0.0 113.768 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.19 -25.45 65.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.641 1.576 . . . . 0.0 114.973 171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.473 ' C ' ' HE ' ' A' ' 61' ' ' ARG . . . -88.78 -13.03 40.41 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.689 1.132 . . . . 0.0 111.05 172.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HE ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -118.61 35.72 0.23 Allowed Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 127.018 2.127 . . . . 0.0 114.748 -166.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.64 -28.1 69.22 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.504 2.136 . . . . 0.0 114.091 -172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -28.73 39.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.583 0.753 . . . . 0.0 112.842 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.92 -48.99 12.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 111.249 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -51.7 -39.09 57.71 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.851 1.205 . . . . 0.0 112.989 173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.63 -47.68 79.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.629 1.172 . . . . 0.0 111.524 173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -71.55 -26.96 62.85 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.72 -27.76 67.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.67 1.123 . . . . 0.0 111.517 164.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 26.41 5.62 Favored Glycine 0 N--CA 1.473 1.143 0 C-N-CA 125.413 1.482 . . . . 0.0 115.307 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -138.84 165.28 27.44 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.877 1.338 . . . . 0.0 113.69 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -165.36 35.7 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.278 1.431 . . . . 0.0 112.609 -167.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -147.62 -153.36 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.183 0.993 . . . . 0.0 112.382 -155.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.4 m -48.5 159.16 0.55 Allowed Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 126.43 1.892 . . . . 0.0 112.91 167.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.34 162.37 4.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.678 3.585 . . . . 0.0 113.189 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 t -159.76 147.33 16.84 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -167.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.09 109.89 22.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.612 1.165 . . . . 0.0 109.02 167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.18 131.57 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.536 1.134 . . . . 0.0 109.466 174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.6 129.92 55.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.131 1.772 . . . . 0.0 110.341 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mm -114.49 139.67 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.773 2.029 . . . . 0.0 108.907 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -157.44 129.89 7.35 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.432 1.493 . . . . 0.0 108.895 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.53 18.72 11.52 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.504 1.122 . . . . 0.0 113.645 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.32 25.18 59.69 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.068 1.318 . . . . 0.0 113.584 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 166.81 23.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.748 1.219 . . . . 0.0 112.388 173.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -79.77 118.16 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 171.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.54 -35.9 22.53 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 174.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -160.44 149.76 17.36 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.538 0.735 . . . . 0.0 112.253 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.8 t -127.3 111.14 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.658 1.583 . . . . 0.0 107.416 167.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -108.27 86.3 2.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.79 1.236 . . . . 0.0 110.872 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 p -85.01 61.99 7.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.822 1.249 . . . . 0.0 111.422 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.3 175.49 33.97 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.466 1.031 . . . . 0.0 115.048 -171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -123.58 145.91 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.631 1.572 . . . . 0.0 110.405 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 12.2 ptp -161.64 -158.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.422 1.089 . . . . 0.0 112.688 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.11 161.88 28.86 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 126.337 1.855 . . . . 0.0 111.089 169.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.25 -35.86 38.91 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 114.366 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.96 -33.49 67.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.104 . . . . 0.0 112.283 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -81.02 -28.41 35.46 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.635 1.174 . . . . 0.0 111.766 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -40.36 95.75 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.284 1.034 . . . . 0.0 111.211 172.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -58.96 -43.34 91.3 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.454 1.102 . . . . 0.0 111.3 170.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.97 -41.9 81.7 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.584 0.754 . . . . 0.0 112.977 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.8 tp -58.7 -46.3 87.62 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.219 1.408 . . . . 0.0 111.078 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -64.04 -52.56 58.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.78 0.832 . . . . 0.0 112.599 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.7 65.76 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.692 0.797 . . . . 0.0 112.248 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.5 m -75.54 -4.96 42.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.623 1.169 . . . . 0.0 113.598 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.82 1.648 . . . . 0.0 109.155 173.627 . . . . . . . . 0 0 . 1 stop_ save_